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Abstract
Ku is an abundant, highly conserved DNA binding protein found in both prokaryotes
and eukaryotes that plays essential roles in the maintenance of genome integrity. In
eukaryotes, Ku is a heterodimer comprised of two subunits, Ku70 and Ku80, that is best
characterized for its central role as the initial DNA end binding factor in the “classical” nonhomologous end joining (C-NHEJ) pathway, the main DNA double-strand break (DSB)
repair pathway in mammals. At the break, Ku directly and indirectly interacts with several CNHEJ factors and processing enzymes, serving as the scaffold for the entire DNA repair
complex. In this work we aim to characterize the role of the Ku70 von Willebrand A-like
(vWA) domain, a protein-protein interaction domain, in Ku’s role in the response to DSBs.
In this study we identified a requirement for the Ku70 vWA domain in both NHEJ
and signaling to the DNA damage response (DDR) pathway to determine cell fate decisions.
We demonstrate that mutation of residues D192A/D195R in helix 5 resulted in extremely
low survival after ionizing radiation (IR) treatment and decreased DNA repair efficiency,
indicating a role for these residues in NHEJ. We also identified a novel phosphorylation
event at Ku70 S155 in response to DNA damage. Mutation of this residue to alanine has no
impact on DNA repair, however results in increased survival and decreased activation of
apoptosis following IR treatment, indicating a defect in the DDR pathway to relay the signal
of failed repair to the cell death machinery. The expression of a phosphomimetic S155D
substitution had the opposite phenotype, with very low survival after IR, and the constitutive
activation of DDR markers and cell cycle arrest even in the absence of any DNA damage.
We found Ku70 S155 phosphorylation was required to interact with and inhibit the Aurora
Kinase B after IR, a kinase that promotes cell cycle progression, to induce cell cycle arrest.
ii

Overall we propose that the Ku70 vWA domain functions to both facilitate the repair of
breaks by NHEJ, and to relay the signal of unsuccessful repair to the DDR in order to
activate cell cycle arrest and apoptosis.

Keywords
Ku, Ku70, DNA repair, NHEJ, vWA, DSB, DNA damage response, phosphorylation,
apoptosis, cell cycle arrest, Aurora B
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Chapter 1

1

Introduction
1.1

General introduction

Structural changes to DNA pose a serious threat to organismal health as the
maintenance of genomic integrity is required for proper cellular homeostasis and the
faithful transmission of genetic material to progeny. Unfortunately, it is estimated that
each cell in the human body is subjected to tens of thousands of genomic insults per day
(1). These DNA lesions can arise spontaneously from physiological processes, such as
meiosis, DNA replication errors, or byproducts from metabolism and inflammation (1).
We are also exposed to numerous environmental damaging agents, including ultraviolet
radiation, ionizing radiation and carcinogenic chemical compounds (1). If not repaired
properly, these DNA lesions can be cytotoxic, or even more problematic, can cause
altered cellular function leading to malignant transformation.
In order to combat the threat of DNA damage, organisms have developed a
complex and sophisticated signaling pathway, collectively termed the DNA damage
response (DDR). The end goal of this process is DNA repair, coordinated enzymatic
processes specific to the type of DNA damage, that restore integrity of the DNA.
Simultaneously, numerous signaling cascades are initiated that induce cell cycle arrest, in
order to give the cell type to repair the DNA, but also activate cell death if the repair
cannot be completed. This thesis will examine the role of Ku, an integral component of

2

the DNA double strand break (DSB) pathway, non-homologous end joining (NHEJ), in
both the execution of DNA repair and coordination of cell fate decisions to the DDR.

1.2
1.2.1

Ku Heterodimer
General introduction

Ku was first identified in the early 80’s as an autoantigen targeted by
autoantibodies in the serum of patients diagnosed with an autoimmune disease known as
scleroderma polymyositis overlap syndrome (2). The name Ku comes from the first two
letters of the name of the original patient in whose serum it was identified.
Autoantibodies directed against Ku were subsequently found in several other
autoimmune diseases, including systemic lupus erythematosus, Sjorgren’s syndrome,
polymyositis and scleroderma (3-5). Early studies using serum from Ku-positive patients
identified Ku as an abundant, mostly nuclear protein (2, 6). Subsequent reports showed
that Ku had unusual DNA binding properties, binding avidly to the ends of doublestranded DNA molecules in a sequence-independent manner and to a lesser extent to
other forms of DNA discontinuities such as hairpins gaps and nicks (6-8). These unusual
end-binding properties made Ku an appealing candidate for a role in DSB repair and
V(D)J recombination, which was confirmed when the two Ku subunits (XRCC5, Ku80
and XRCC6, Ku70) were found to complement the DNA repair defect of several IRsensitive cell lines (9-15). It is now well established that while not essential to individual
life in the short term, Ku function is critical to the maintenance of genomic integrity and
to the proper cellular and organismal development. A better understanding of Ku’s
diverse roles at the cellular and organismal level have implications for the study and the
treatment of other human diseases, such as immune system disorders, cancer and aging.
2

3

1.2.2

Ku Structure
Ku is a highly abundant protein found in vivo as a stable heterodimer consisting of

two subunits, Ku70 and Ku80 (70 and 80 kDa, respectively). Both Ku70 and Ku80
eukaryotic Ku subunits contain three domains (Figure 1-1A): an N-terminal alpha
helix/beta barrel von Willebrand A (vWA) domain; a central core domain required for
DNA binding and dimerization; and a helical C-terminal domain.
The Ku70/80 crystal structure (Figure 1-1B) shows that the two subunits dimerize
through the central domain to form a ring capable of accommodating two turns of doublestranded DNA (approximately 14 base pairs) (16). This ring, consisting of intertwined
strands of both Ku70 and Ku80, is lined with positively charged residues positioned to
interact with the sugar phosphate backbone of DNA in a sequence-independent manner.
Ku binds double-stranded DNA ends with high affinity (Kd~10-9 M), including 5’-3’ or
3’-5’ overhangs and blunt ends, however has significantly less affinity for circular DNA
and single-stranded DNA ends (6, 17, 18). Ku has a preferred orientation when loaded
onto the DNA, placing Ku70 proximal to the DNA end, and Ku80 on the distal side,
facing away from the end (16).
The N-terminal vWA domain (also called α/β domain) consists of a six-stranded
beta-sheet in a Rossman fold. The amino side of the beta-sheet makes contact with the
DNA groove, although it contributes little to Ku70/80 dimerization or DNA binding. The
carboxyl end of the fold points away from the break, which makes it available as a
protein-protein interaction surface (16). This domain, named for its prototype protein, the
von Willebrand Factor type A, is present in mostly extracellular matrix proteins but also
several intracellular proteins, where it facilitates protein-protein interactions with a wide
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Figure 1-1 Representation of Ku structure
(A) Schematic diagram of domain representation of the Ku70 and Ku80 subunits. The
subunit domain structure of yeast and human Ku consists of the alpha helix, beta barrel
N-terminal vWA domain, a central DNA binding core and a C-terminal helical domain
(CTD). The eukaryotic Ku80 CTD contains the region required for binding DNA-PKCS ,
while the Ku70 CTD is shorter and contains a SAF-A/B, Acinus and PIAS domain
(SAP). The location of the nuclear localization signals and post translation modifications
(phosphorylation and acetylation) on the human Ku protein is indicated. Yeast Ku is
comprised of a similar domain structure to human Ku, except for a truncated C-terminal
domain in Ku80. Prokaryotes encode for a single Ku subunit that is homologous to the
eukaryotic core DNA binding domain. (B) The crystal structure of human Ku (PDB:
IJEY) coloured according to the domain structure. The dimer forms an asymmetrical
basket structure with a positively charged ring large enough to accommodate two turns of
the DNA. The Ku80 C-terminus is not included in this crystal structure.
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variety of ligands (19). Overall, the function of this domain is not well characterized but
there is emerging evidence that it has an important role in DSB repair and telomere
regulation. In Saccaromyces cerevisae, mutations in helix 5 of Ku80 abrogated telomere
silencing, while mutations in helix 5 of Ku70 had a negative impact on DSB repair in
yeast and mouse cells (20-22). Specific residues in the Ku70 vWA domain were also
shown to be critically implicated in conferring abasic site processing by Ku in vitro (23,
24). Additionally, another region of the human Ku70 vWA domain in helix 4 was found
to regulate DNA damage signaling to apoptosis (22). Consistent with its predicted role as
a protein-protein interaction surface, the vWA domain has been shown to mediate an
interaction with both the telomere complex component telomere repeat binding factor 2
(TRF2) and NHEJ factor aprataxin and PNKP like factor (APLF) (21, 25).
Both Ku subunits contain a helical C-terminal domain (CTD), however this is the
most divergent region of the two proteins. The Ku80 CTD is approximately 15 kDa and
contains a helical and a disordered region. In vertebrates, the extreme Ku80 C-terminus is
involved in the recruitment of DNA-dependent protein kinase catalytic subunit (DNAPKCS) to DNA (26, 27). Lower eukaryotes, such as S. cerevisiae and Aradopsis thaliana,
encode for a smaller Ku80 protein, missing this DNA-PKCS binding region, which
correlates with the fact that DNA-PKCS is not present in these organisms. The Ku70 CTD
is composed of a highly flexible linker region followed by a structured 5 kDa helix-loophelix region known as the SAP domain (named after SAF-A/B, Acinus and PIAS motifs)
(28). The SAP domain has putative DNA binding properties and has been shown to
increase the overall DNA binding affinity of the heterodimer (29, 30). This C-terminal
region is also subject to post translational modifications. Multiple C-terminal lysine
6

7

residues are acetylated to regulate Ku interaction with pro-apoptotic proteins (31, 32).
Acetylation and sumoylation of Ku70’s C-terminal tail were also implicated in
modulating its recruitment to DNA damage sites and Ku’s DNA binding affinity,
respectively (32, 33). The Ku70 SAP domain was also shown to mediate the recruitment
of homeodomain proteins to DNA ends (34). Furthermore, Ku is primarily a nuclear
protein, and the CTD in both subunits contains the basic nuclear localization signal motif
that regulates the heterodimer’s nuclear transport (35).
It is currently unclear whether Ku subunits can exist alone in a monomeric form,
but there is strong evidence that Ku is an obligate heterodimer. Cells derived from Ku70
deficient mice show very low expression of Ku80, and similarly, the expression of Ku70
is severely reduced in cells derived from Ku80 deficient mice (15, 36, 37). This
phenomenon is also observed in yeast strains null for either Ku subunit, and in fact, these
strains are phenotypically identical to the double Ku subunit knockout strain (38). This is
likely due to the instability of each subunit in the absence of their interacting partner, as
exogenous re-expression of the missing subunit restores the protein levels of its
heterodimeric partner (37). Overall, evidence suggests that the individual Ku subunits are
unstable and require heterodimerization to function.
The Ku subunits share little primary sequence, but do have a conserved secondary
structure, indicating that they may be derived from a common ancestor. Ku is an
evolutionarily conserved protein, found in both the prokaryotic and eukaryotic kingdoms,
and its overall structure is preserved throughout. As several homologues have been
identified in bacterial and archaea species, Ku is thought to have prokaryotic origins (39,
40). For the most part, prokaryotic genomes contain a single copy of a Ku-like protein
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which also functions in a bacterial NHEJ pathway, but as a homodimer (41). While
having little DNA or protein sequence similarity to its eukaryotic counterparts,
prokaryotic Ku homologues display structural homologies to the central core DNA
binding domain region of both eukaryotic Ku subunits and form homodimers that bind
double-stranded DNA ends (42). Prokaryotic Ku is much smaller however, only
approximately 30-40 kDa, lacking both the vWA and C-terminal domains found in
eukaryotes (39, 40).

1.3
1.3.1

DNA Repair
Types of DNA damage and repair

DNA is subject to a wide variety of chemical modifications as a result of damage
from both extrinsic and intrinsic agents. In order to resolve this diverse collection of
modifications, several separate DNA repair pathways have evolved. The simplest DNA
damaging agent is hydrolysis, which deletes DNA bases by severing the N-glycosidic
bond between the base and the deoxyribose, as well as the deamination of bases that
create conversions (eg. uracil to cytosine) (43-45). Other base modifications are produced
from endogenous reactive molecules like nitric oxide (NO-) and reactive oxygen species
(ROS) (46, 47). These base damages that do not distort DNA structure are generally
resolved through the base excision repair (BER) pathway (48). Larger lesions that do
distort the DNA structure are repaired by the nucleotide excision repair (NER) pathway
(49). Examples of these bulky lesions are the pyrimidine dimers formed by UV radiation,
or DNA intra-strand crosslinks created from drugs such as cisplatin (50). The mismatch
repair (MMR) pathway is utilized in the correction of DNA polymerase errors like
insertions, deletions or incorrect base incorporation (51-53). Finally, there are both single
8
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strand break (SSB) and double strand break repair (DSBR) pathways that are utilized
when the DNA damaging agent severs the sugar phosphate backbone of DNA (54).
The DNA DSB is considered to be the most dangerous and lethal form of DNA
damage. DSBs can arise from both exogenous sources, such as ionizing radiation (IR),
chemotherapeutic drugs and endogenous sources, such as meiosis, immune system gene
rearrangements, stalled replication forks and reactive oxygen species (ROS) (1). All
organisms are exposed to low levels of environmental IR and to varying amounts
throughout our lifetime during medical procedures such as X-rays and cancer treatment
(1). IR is a particularly complex DNA damaging agent due to the wide variety of DNA
damage it produces. The DNA is initially damaged through the direct deposition of
energy, but also, the ionization of surrounding water molecules produces ROS, which
themselves damage the DNA (55). As a consequence, 1 Gy of IR produces approximately
40 DSBs per cell, but also 1000 single-strand breaks (SSBs), and 2000 base
modifications (56-58). DSBs generated from IR can often be complex, clustered lesions
that contain additional single strand overhangs and base damage that require additional
processing before repair. There are three main DSB repair pathways in eukaryotes
(Figure 1-2): the classical NHEJ (C-NHEJ), alternative NHEJ or microhomologymediated end joining (A-NHEJ or MMEJ) and homologous recombination (HR) (59-61).
C-NHEJ and A-NHEJ have the potential to be active in all stages of the cell cycle,
however HR, is only active in the S and G2 phases because it utilizes the
complementarity of the sister chromatid to repair the DSB with high accuracy (60, 61).
C-NHEJ is capable of ligating any two DNA ends, regardless of sequence. Due to this
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Figure 1-2 Schematics of the double-strand break repair pathways in higher
eukaryotes.
(A) Homologous Recombination. After the introduction of a DSB, the ends are
recognized by the MRN complex (Mre11-Rad50-NBS1), which recruits proteins Sae2,
Sgs1, Exo1 and Dna2 to facilitate resection of the break in the 5’ direction and leave 3’
single-stranded extensions. The 3’ single-stranded overhangs are bound by the proteins
RPA, Rad51, and Rad54 to form a nucleoprotein filament. The next step, aided by the
recruitment of Rad52, is the invasion of this filament strand into the DNA of the
homologous chromosome to form a D-loop structure. A polymerase extends the 3’
overhang to create a cross structure known as the Holliday junction, which is later cut to
resolve the chromosome.

(B) Alternative end joining/microhomology-mediated end

joining (A-NHEJ/MMEJ). The break is recognized by the MRN complex, PARP1 and
XRCC1, which promote the nucleolytic degradation of DNA to reveal 5-25 bp regions of
microhomology between the DNA strands. After the alignment of complementary
regions, the gaps are filled in by polymerase β, and ligated by either ligase I or ligase III.
(C) Non homologous end joining (C-NHEJ). (1) The ends are recognized by the Ku
heterodimer which slides directly onto the break via its DNA binding ring. The PIKK
member DNA-PKCS binds at the Ku80 C-terminus to create the DNA-PK complex. (2)
DNA-PK autophosphorylates to create the catalytically active DNA-PK complex.
Artemis is recruited to DNA-PK and phosphorylated. (3) Several enzymes, including
polymerases (polymerase µ or λ), nucleases, kinases (polynucleotide kinase) are recruited
to the break and remove damaged bases or single-strand overhangs to create compatible
ends for ligation. (4) The ligation complex, consisting of Ligase IV, XRCC4, and XLF
are recruited by Ku and ligate the two DNA ends. (5) It is unclear how the Ku dimer is
removed from the ligated break. Possible mechanisms include degradation of Ku by
proteases and the ubiquitin pathway, or physical nicking of the repaired DNA by
nucleases to allow Ku to slide off.
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flexibility, C-NHEJ is the predominant DSB repair pathway in humans and other higher
eukaryotes (62-64).

1.3.2

Classical Non Homologous End Joining (C-NHEJ)

1.3.2.1

Overview

C-NHEJ can be divided into five main stages: I) recognition of the break by Ku,
II) Synaptic end bridging, III) DNA end processing to produce compatible ends, IV)
ligation of the break, and finally, V) Ku removal from the restored DNA. The importance
of Ku to DSB repair has been well documented with reports of Ku deficient cells
displaying inaccurate end-joining, dramatic radiosensitivity, and chromosomal breakage,
translocations and aneuploidy (15, 65-69).

1.3.2.2

DNA end recognition

The initial step of C-NHEJ is the rapid recognition of the DSB by Ku. Ku’s
abundance (in humans, approximately 500,000 molecules per cell (6, 16, 70)) and strong
affinity for DNA allows it to associate with DNA ends within 5 seconds of damage (71).
Ku binding has a protective role and in Ku-deficient cells, nucleolytic processing occurs
at DSB ends (72). Once Ku has encircled the DNA via its central ring domain, it directly
and indirectly interacts with several NHEJ factors, serving as the scaffold for the entire
NHEJ complex. Some uncertainty remains as to how many Ku molecules are recruited to
a DNA break. Many DNA damage response factors form distinct foci easily visible at the
site of DNA damage. However there has been difficulty in observing Ku following DNA
damage by microscopy, leading to the conclusion that Ku does not accumulate in large
numbers at a DSB. Furthermore, an in vitro study showed that only one or two Ku
molecules were able to load onto a chromatin substrate (73). A recently developed
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method for visualizing Ku foci also demonstrated that on average there are only two Ku
molecules present at a DSB in vivo, presumably one at each end of the DNA break (74).

1.3.2.3

Bridging of the DNA ends

Ku is the DNA binding subunit of the DNA-dependent protein kinase (DNA-PK)
complex, which comprises Ku and DNA-PK catalytic subunit (DNA-PKCS), a member of
the phosphoinositide 3-kinase-related kinase (PIKK) family (75). DNA-PKCS activity is
very important for successful DNA repair, as loss of DNA-PKCS activity through
mutations or knockout, strongly diminishes C-NHEJ efficiency and, at the organismal
level, results in profound immunodeficiency (11). The low-resolution electron
microscopic structure of the DNA-PK complex indicates that Ku70/80 makes several
contacts with DNA-PKCS, including the N-terminal and C-terminal regions of DNA-PKCS
(76). At DSBs, DNA-PKCS is recruited by Ku to form the active complex, leading to Ku
translocation and the eventual activation of DNA-PKCS catalytic activity. This
translocation allows DNA-PKCS to be positioned at the tip of the break and mediates the
synaptic joining of the two broken ends and the stabilization of the complex (77).
Another important consequence of DNA-PK kinase activation are 15 autophosphorylation events on DNA-PKCS (78-82). Ku70 and Ku80 were shown to be
phosphorylated by DNA-PK in vitro, however the importance of these events in C-NHEJ
function is unclear, as mutation of these residues does not impact cell survival after
ionizing radiation (IR) (83). Similarly, DNA-PK phosphorylates several NHEJ factors in
vitro such as DNA ligase IV, X-ray cross complementing protein 4 (XRCC4), XLF
(XRCC4 like factor, also known as Cernunnos) and Artemis but again many of these
were dispensable for NHEJ in vivo (80, 84-86).
13

14

There is increasing evidence that, along with DNA-PKCS, Ku itself mediates the
DNA end bridging and stabilization of the C-NHEJ ligation complex. Several early
observations lead to the conclusion that Ku functions to bridge DNA ends, including the
in vitro joining of two radiolabelled DNA ends by recombinant Ku protein and the
visualization of Ku dependent DNA fragment joining by electron and atomic force
microscopy (87, 88). More recently, utilizing an experimental system designed to
visualize DSBs introduced by restriction endonucleases in mammalian cells, it was
observed that the loss of Ku80 resulted in increased distance between DNA ends (89).
Despite these observations, there has been little insight into the precise mechanism of Ku
end bridging. A mutation in helix 5 of the Ku70 vWA domain, noted for its ability to
impair DSB repair in both yeast and mammalian cells, was found to decrease
multimerization of Ku proteins, leading to the speculation that this helix mediates DNA
end bridging through the binding of two Ku70 molecules (20-22).

1.3.2.4

DNA end processing

Between the initial break recognition by Ku and the final ligation of the break,
there is considerable flexibility in the factors involved in repair. For example, IR is
known to produce a variety of damage to the DNA, occasionally leaving non-ligatable 3′phosphate groups, 3′-phosphoglycolates, or 5′-hydroxyl groups. Therefore, a number of
kinases/phosphatases (polynucleotide kinase/phosphatase (PNKP), nucleases (Werner,
Mre11, Artemis, ExoI), polymerases (DNA polymerases µ and λ), helicases (RECQ1),
and phosphodiesterases (tyrosyl-DNA phosphodiesterase 1) may be required to produce
compatible DNA ends (90). In the case of DSBs induced by Topoisomerase II (TOP2)
poisons, TOP2 remains covalently linked to via a phosphotyrosyl bond to the 5’ terminus
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and requires a specific end-processing enzyme, tyrosyl DNA phosphodiesterase 2
(TDP2), that hydrolyses 5’-phosphotyrosyl bonds at TOP2-associated DSBs (91, 92). In
many cases, recruitment of these factors to the DNA break is dependent on Ku, with
some factors directly interacting with Ku (Table 1-1). Interestingly, Ku itself has been
shown to have some enzymatic activity and may also participate in the processing of
DNA ends. It was identified as a 5′-dRP/AP lyase that removes abasic sites by nicking
DNA 3' of the abasic site via a mechanism involving a Schiff-base covalent intermediate.
Several lysine residues in the Ku70 vWA domain catalyze this reaction, notably
K160/164, which when mutated to an alanine residues completely inhibit Ku’s ability to
form a Schiff base (23, 24).

1.3.2.5

Ligation of the break

Following end-processing, the two DNA ends are ligated back together. Ku also
has an important role in the recruitment of the ligase complex, which is comprised of
DNA ligase IV, XRCC4 and XLF. The complex requires Ku to be recruited to the break
through a direct interaction with Ku, with DNA ligase IV and XLF interacting with the
whole heterodimer and XRCC4 interacting with Ku70 specifically (71, 93-96). There is
still great uncertainty regarding the stepwise recruitment of NHEJ factors following Ku
binding, although this is not surprising given that different processing enzymes are
required in different situations. Indeed there is also some evidence that high complexity
DSBs (containing single-strand overhangs, base oxidation and abasic sites) are repaired
with slow kinetics and are dependent on DNA-PKCS activity, while low complexity DSBs
(without surrounding DNA damage) do not require DNA-PKCS binding, and are
efficiently ligated with only Ku and the ligation complex (97-100).
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Table 1 Ku protein-protein interactions.
A list of proteins proposed to directly interact with Ku, classified according to cellular
process.
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1.3.2.6

Ku removal from the DNA

One of the outstanding questions in NHEJ is how Ku is removed from DNA
following ligation of the DSB. Ku is rapidly recruited to the break, but is only found there
transiently, as laser micro-irradiation studies found that Ku signal steadily depletes within
the few hours following the initial damage, presumably being removed as DNA is
repaired (71, 101). Ku differs from many other DNA binding proteins in that it binds
DNA ends by encircling them through its ring domain, which would suggest that once the
two DNA breaks are ligated, Ku is trapped on the linear repaired DNA. Furthermore, the
crystal and electron microscopy (EM) structures do not indicate an obvious escape
mechanism given that the vWA and central ring domain conformations of Ku remain
unchanged whether or not bound to DNA (16, 76). One possible mechanism is that the
removal of Ku from DNA occurs via a protein degradation pathway. Studies in Xenopus
laevis have shown that poly-ubiquitination of Ku80 Lysine 48 leads to its degradation by
the Skp1-Cul1-Fbxl12 (SCF) E3 ubiquitin ligase complex (102). Similarly in human
cells, Ku80 ubiquitination was found to be dependent on the E3 ubiquitin ligase RING
finger protein 8 (RNF8) (103). The depletion of RNF8 led to increased Ku80 retention at
the break and decreased NHEJ efficiency, suggesting that removal of Ku80 by ubiquitinmediated degradation is an important step in successful DSB repair (103). Another
proposed mechanism for Ku removal is the direct nicking of DNA to allow Ku escape.
Evidence for this has emerged from yeast systems, with the HR complex MRX (Mre11Rad50-Xrs2) performing an endonucleolytic incision adjacent to the DNA end, followed
by digestion of the DNA to allow Ku removal and then restoration of the DNA by MRX
and Dna2 resection (104-106). Overall, protein degradation and direct DNA nicking are
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very different possible mechanisms for Ku removal and further work needs to be done to
resolve this discrepancy. It should be noted that these results were obtained from different
biological systems and could indicate that there is a divergence in Ku removal
mechanisms between yeast and higher eukaryotes.

1.3.3

Competition between repair pathways
There is much investigation regarding how organisms regulate the DSB repair

pathway choice and increasing evidence suggests that Ku has an inhibitory effect on the
other DSB pathways. Ku is one of the first proteins found at DSB regardless of cell cycle
stage and cells will first attempt to repair DSBs by C-NHEJ if the ends are compatible
(101, 107-109). HR is the preferred pathway in the S and G2 phases, and the initial end
binding factors of HR, for example Mre11, antagonize Ku for DNA end binding. The
binding of HR factors initiates DNA end resection to produce single-stranded DNA,
which Ku does not have a strong affinity for, and promotes the completion of DSB repair
by HR (61). In yeast, Ku appears to outcompete HR factors in G1 phase, as the loss of Ku
results in increased Mre11 recruitment and Exo1 mediated resection (72, 110-113).
Overexpression of Ku is even able to reduce recruitment of Mre11 in G2, when HR is the
preferred DSB repair pathway (110). The HR inhibitory effect appears to be specifically
dependent upon Ku’s DNA end binding function, as deletion of other NHEJ factors, such
as ligase IV, were not able to increase HR activity to the same extent (110). Another
study has implicated, not only Ku binding, but the kinase activity of DNA-PKCS in the
DNA repair pathway choice, as initiated of HR in G2 depended upon DNA-PKCS
autophosphorylation events (114). Ku70 also antagonizes HR via the Fanconi Anemia
(FA) and break-induced replication (BIR) repair pathways. The FA pathway repairs DNA
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interstrand cross-links (ICLs) in cooperation with the HR pathway during replication
(115). Cell lines deficient in FA genes display increased sensitivity to DNA damaging
agents that specifically create DNA cross-links and show a greater dependence on repair
by NHEJ. The simultaneous deletion of Ku70 however, reverses this sensitivity, and
repair is completed by HR once again (116). Similarly, BIR is responsible for the repair
of breaks that occur in S phase following a replication fork collapse (117). This pathway
is also dependent on HR, and yeast cells null for Mre11 activity are sensitive to agents
that induce replication stress (118). Several Ku70 mutants were identified that rescue this
Mre11 loss, again suggesting a competitive interplay between Ku and Mre11 (118, 119).
A-NHEJ is Ku-independent end joining, and while it is not currently fully
characterized, it is considered to be a more mutagenic DSB pathway as it occasionally
utilizes microhomologies far from the DSB which results in extended resection and
deletions at the repair site (59, 60, 120, 121). Similar to C-NHEJ, this pathway is active
in all phases of the cell cycle, however it was only identified after the deletion of
essential C-NHEJ components, suggesting that this pathway is secondary to C-NHEJ (57,
120, 122). It is still unclear why A-NHEJ may be selected over the less mutagenic CNHEJ pathway, however A-NHEJ, similar to HR, often begins with resection to form
SSBs, which would inhibit Ku binding and promote the binding of A-NHEJ factors, such
as PARP-1(59, 60, 120, 121). Ku outcompetes the DNA binding factor PARP-1, and
deletion of Ku results in increased repair by this pathway (123-125). Furthermore the
DNA-PK complex has an inhibitory effect on the enzymatic activity of PARP-1 (126).
Studies have indicated that human somatic cell lines with Ku80 deletions retain DSB
repair capability, but show a shift towards the A-NHEJ pathway (127). However Ku8019
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expressing cell lines with individual deletions of the other proteins required for C-NHEJ
have a dramatic decrease in all DSB repair pathways (127). These results suggest that the
binding of Ku, or the entire DNA-PK complex to DNA has a dominant negative effect on
the other DSB repair pathways if C-NHEJ cannot be completed.
The DNA repair pathway choice is largely determined by cell cycle stage, with
breaks in G1 phase repaired by end joining, and breaks in G2/S phases largely repaired
by HR. Not surprisingly, members of the cell cycle machinery, namely the cyclindependent kinases (CDKs), have been implicated in regulating the activity of several
DNA repair factors (128, 129). Several studies have shown, in both yeast and mammalian
systems, that CDKs phosphorylate the HR factors CtBP-interacting protein (CtIP) and
Dna2 in order to initiate the switch to recombination at the G1/S transition (130-132).
There is some evidence that Ku could also be regulated by CDK phosphorylation. Cyclin
A1/CDK2 was implicated in the regulation of NHEJ following radiation and was
proposed to be a binding partner of Ku in vertebrates (133). Furthermore, mass
spectrometry studies revealed potential CDK phosphorylation sites on Ku (134, 135).
However, the functional significance of Ku phosphorylation by CDKs has yet to be
elucidated. While several potential CDK1 phosphorylation sites were identified in S.
cerevisae Ku, mutation of these sites did not elicit a DNA repair defect (136).
Recent work has also implicated the factors p53 binding protein 1 (53BP1) and
breast cancer 1 (BRCA1) as essential regulators in the pathway choice in mammalian
cells. 53BP1, along with RAP1 interacting factor (Rif1) and Pax transactivation domaininteracting protein (PTIP), promote NHEJ and negatively regulate resection in G1 phase
(137, 138). BRCA1, along with CtBP-interacting protein (CtiP), promotes the removal of
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53BP1 during the switch to HR at the G1/S transition (139). It is currently unclear how
Ku fits into this mechanism, however there is evidence that Ku associates with BRCA1
and that this interaction is important for successful NHEJ in G1 (140-142). It is possible
that this association is essential for the removal of Ku from breaks, with BRCA1 utilizing
the exonuclease activity of the MRN (Mre11-Rad50-NBS1) complex in a nicking
mechanism analogous to that proposed for yeast Ku removal.

1.3.4

Role of Ku in other DNA repair pathways
In addition to its role in the repair of DSBs by C-NHEJ, Ku has been implicated

in a number of other DNA repair pathways. Ku has been implicated in base excision
repair (BER), which repairs DNA base damage, apurinic/apyrimidic (AP) sites and
single-strand breaks (SSBs) (48). Cells deficient in Ku70 and Ku80 were sensitive to
reactive oxygen species (ROS) and alkylation damage producing agents that result in
base lesions and SSBs (143). Additionally, in vitro experiments demonstrated that Ku
subunits bind AP sites and cell extracts from Ku deficient cells have decreased BER
activity (143, 144). Furthermore, Ku has been shown to interact with ABH2, an enzyme
involved DNA alkylation repair, potentially implicating it in this pathway as well (145).

1.4

Ku at Telomeres

Telomeres are the linear ends of chromosomes and therefore have the potential to
be recognized as DSBs and processed by DSB repair pathways. Specific protein
complexes, such as the shelterin complex in mammals and the Rap1 or CST (Cdc13–
Stn1–Ten1) complexes in yeast have evolved to bind and form protective caps on the
DNA ends to prevent access by the DNA repair complexes (Figure 1-4) (146, 147). A
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Figure 1-3 General structure of telomeres
In most eukaryotes telomeric DNA consists of extended tracts of G-rich repeat arrays.
The G-rich strand forms a short 3’ single-strand protrusion called the G-overhang, which
mediates the formation of a complex secondary structure called a t-loop. The t-loop
structure allows the folding of the end of the chromosome to mask and protect the DNA
end

from

degradation.

A.

Structure

of

the

yeast

telomere.

The

MRX

(Mre11/Rad50/Xrs2) and Sir/Rap1 complexes directly bind the telomeric DNA (281). Ku
could potentially (a) bind the DNA end via its DNA binding domain or (b) bind via a
protein-protein interaction with telomeric complexes (such as Sir/Rap1). Ku has a role in
recruiting telomerase, mediated by an interaction with the TLC1 RNA and Ku80. Ku
interaction with the telomere may be indirect, requiring the heterotetramerization of two
Ku

molecules.

B.

Structure

of

the

mammalian

telomere.

The

Shelterin

(TRF1/TRF2/Tin1/Pot1/TPP1) and MRN (Mre11/Rad50/Nbs1) complexes coat the
telomeric DNA to protect from degradation (282). Again there is controversy whether (a)
Ku directly binds the telomeric DNA or (b) is retained through a protein interaction with
components of the Shelterin complex (such as TRF1/TRF2).
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role for Ku in the maintenance of telomeres in yeast has been long established.
Foundational to this was the observation that deletion of either Ku subunit in S. cerevisae
resulted in shortened telomeres and long G-tails compared to wildtype (148-150). The
requirement of Ku for proper telomere structure and maintenance appears to be separate
from C-NHEJ, as DNA Ligase IV deficient strains, the ligase essential for completion of
C-NHEJ, do not show any telomere defects (151). Analysis of telomeres in Ku-deficient
mice has produced conflicting results regarding telomere length, with reports of telomere
shortening as well as lengthening (152-154). Despite this, the same mice exhibit
increased telomere end-to-end fusions and chromosomal aberrations (153, 154).
Similarly, human cells with deleted Ku80 show telomere loss and abnormal telomere
structure, overall indicating a clear role for Ku in proper telomere structure maintenance
in mammals (155).
Similar to its role in protecting the DNA ends of DSBs in NHEJ, Ku protects
telomere ends from recombination and degradation events (148-150, 152-154).
Paradoxically, although Ku promotes the fusion of dysfunctional, or uncapped, telomere
ends, it has an inhibitory effect on the HR and A-NHEJ pathways and on the
recombination of normal telomeres. Mouse embryonic fibroblasts (MEFs) deficient in
Ku70 have normal telomere structure, however they exhibit increased sister telomere
exchanges mediated by HR and chromosome fusions by the A-NHEJ pathway (156, 157).
Additionally, Ku deficient S. cerevisiae display increased RAD52 dependent
recombination of the subtelomeric DNA elements, consistent with its general HR
inhibitory function (158, 159). While wildtype cells only exhibit long G-tails during late
S phase, yeast Ku deficient strains possess long G-tails throughout the cell cycle. This
24

25

defect is almost completely suppressed by the deletion of the 5’ to 3’ exonuclease Exo1,
suggesting that Ku acts to inhibit inappropriate nucleolytic degradation of the C strand by
nucleases (160).
Ku also positively regulates telomere length through telomere addition by aiding
in the recruitment of telomerase. In yeast, Ku has been shown to interact with telomerase
component 1 (TLC1), the telomerase RNA subunit, via binding of TLC1’s 48nt stemloop region (161, 162). Deletion of the binding interface from either the Ku80 vWA
domain or the TLC1 stem-loop results in decreased telomere length and decreased de
novo telomere addition, perhaps due to the decreased levels of TLC1 RNA or altered
localization of the telomerase holoenzyme (161, 163-166). There is no sequence
conservation between TLC1 and the human telomerase RNA counterpart, hRT, however
there is evidence that the interaction between the RNA component of human telomerase
(hRT) and Ku in humans is conserved (167). Another study detected an interaction with
Ku and telomerase in human cells, however this interaction was reported to occur through
the catalytic reverse transcriptase protein subunit hTERT (168).
The phenomenon of the telomere position silencing effect (TPE), observed in
many eukaryotic species, is the process by which organisms transcriptionally silence
genes located near the telomere (reviewed in (169, 170)). In S. cerevisiae, Ku, along with
the silent information regulator (Sir) complex, are essential for TPE, as deletion of either
Ku subunit results in complete loss of telomeric silencing (171-174). As a consequence of
this role, Ku is also involved in the nuclear organization of telomeres. Telomeres and
TPE proteins in S. cerevisiae are found distinctly clustered in foci around the nuclear
periphery, and the loss of Ku function often results in the random distribution of
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telomeres throughout the nucleus (174-176). Ku participates in these processes as part of
multi-protein complexes with various proteins (such as the Sir proteins, Rap1 and Mps3)
and Ku is particularly essential for their formation in the G1 phase of the cell cycle (176178).
It is still currently unknown how Ku is associated with the telomere in vivo,
whether it is through direct DNA binding of the end, or is mediated through a proteinprotein interaction with another telomere bound factor. Ku has the ability to directly bind
telomere DNA in vitro, in both mammals and yeast (179, 180). Furthermore, mutations in
yeast Ku’s DNA binding domain reduces association with telomeric chromatin and
renders it unable to protect the telomere end, suggesting that this region is key for
telomere binding (181). Despite this evidence, there is still some question whether it truly
slides onto the telomere end via its DNA binding ring. Telomeres in many species form
higher order loop structures designed to conceal the end from attack by Ku and the DSB
repair pathways, so further research needs to be done to understand how and when Ku
would be allowed access to the telomere end.
Another possibility is that Ku is retained at the telomere through protein-protein
interaction with other telomere bound factor(s). Ku has been shown to interact with
TRF1, TRF2 and Rap1 (21, 182-186). These components of the shelterin complex bind
DNA directly and then mediate the recruitment of other shelterin factors, such as TERF1interacting nuclear factor 2 (TIN2) to the TRF proteins in humans and Sir3/4 to Rap1 in
S. cerevisiae, and therefore could also be involved to recruit Ku at the telomeres (187,
188). A longstanding model for telomerase recruitment by Ku in yeast, suggested that Ku
bound to the telomere end through its DNA binding ring and then bound the TLC1 RNA
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via the yeast Ku80 vWA domain (161). However there is evidence that Ku requires the
DNA binding domain for both DNA and RNA binding and cannot bind both
simultaneously (189). These observations suggest that Ku does not recruit telomerase to
the telomere by binding the telomere directly, and instead favours a model where Ku
must bind another telomere bound factor to be retained. A combination of DNA binding
and protein interaction is also possible and has been reported for the shelterin component
protection of telomeres 1 (POT1), which was shown to bind the G-strand of telomeres, as
well as form multiple protein interactions (190, 191). Given that Ku has been shown to
multimerize, it is possible that one Ku molecule interacts with the telomere end then
multimerizes with another Ku molecule that is bound to telomerase. Although it appears
that there are similarities in Ku telomere binding between yeast and mammalian systems,
these organisms have different telomere structure and protein complexes present, so it is
possible that Ku has different mechanisms for telomere binding and protection. Advances
in high-resolution microscopy techniques have allowed for direct visualization of
telomere structures, such as mammalian t-loop formation by TRF2, and could help in
understanding Ku’s role at the telomere (192).

1.5
1.5.1

DNA Damage Response
Overview

The DNA damage response (DDR) (Figure 1-4) is a carefully orchestrated
signaling cascade that senses DNA damage and promotes DNA repair to salvage the cell,
but also carries out cell fate decisions to protect the overall health of the organism (193).
The early stages of the DDR involve the building of a large multi-protein complex at the
site of damage, followed by numerous post-translational modifications (including
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Figure 1-4 Overview of DNA double-strand break (DSB) recognition and DNA
Damage Response (DDR).
After the introduction of a double-strand break (DSB), the broken DNA end is rapidly
recognized by the Ku heterodimer and the MRN complex (Mre11/Rad50/NBS1). Next is
the recruitment of the PIKK family members DNA-PKcs, bound to Ku, and ATM, which
both phosphorylate the histone variant H2AX on its C-terminal residue Ser139 (to yield
γ-H2AX). The MRN complex promotes the activation of ATM molecules, which in turn
further amplify H2AX phosphorylation and spread the γ-H2AX signal far from the initial
damage site. Several other factors are phosphorylated by ATM and recruited to the
damaged site in large numbers, including MDC1, 53BP1, Rif1 and BRCA1. ATM also
initiates a signaling cascade through the phosphorylation of p53 and Chk1/2 that results
in broad transcriptional changes to induce cell cycle arrest or activate apoptosis if the
damage is unable to be repaired (193).
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phosphorylation, ubiquitination, acetylation, sumolyation, methylation and ribosylation)
to the proteins and surrounding histones. The resulting chromatin modification and
reorganization allows access to the DNA for processing and repair to occur (194).
Simultaneously, the activation of transducer proteins, mainly kinases, activates numerous
downstream effector molecules to induce broad transcriptional changes throughout the
cell. This cascade is required to initiate cell cycle checkpoints, and if necessary,
programmed cell death and senescence, two mechanisms that eliminate cells damaged
beyond repair. The failure to properly execute the DDR can have devastating
consequences to the health of an organism, as it can allow DNA damage to persist,
resulting in genomic instability and perhaps cellular transformation and cancer.

1.5.2

ATM
The serine/threonine kinase ATM of the PIKK family of kinases is the chief

regulator of the DDR (195, 196). ATM has an impressive list of cellular targets including
proteins involved in DNA repair, cell cycle regulation, and cell death pathways (197).
One of the critical events in ATM signaling is the phosphorylation of p53, a transcription
factor that has broad transcriptional control over many cell survival and cell death
effector proteins (198). Another well-characterized target is the histone H2A variant,
H2AX, which is phosphorylated on its C-terminal tail at residue serine-139.
Phosphorylated H2AX (commonly known as ϒ-H2AX) serves as a docking site nearby
the DSB for repair factors to accumulate and form large foci (199, 200). H2AX
phosphorylation often propagates kilo- to megabases from the initial damage site, making
it easily observable by fluorescent microscopy, and is therefore commonly used as a
marker for DSBs (199, 200).
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The activation of ATM is dependent on both post-translational modifications and
protein-protein interactions. Several proteins are recruited to the DSB foci that are
required for full ATM activation. Some of the first proteins recruited to the DSB are the
Mre11-NBS1-Rad50 proteins (forming the MRN complex), which create a bridge
spanning the DSB and play roles in both repair through HR and DDR signaling. The
MRN complex activates ATM through an interaction with the NBS1 subunit, and this
interaction is further stabilized through the activities of neighboring foci proteins, namely
53BP1 and BRCA1 (195, 196). ATM activation is also mediated by the scaffolding
protein, MDC1, which binds ϒ-H2AX and ATM, tethering ATM to the chromatin (195,
196). ATM directs its own positive feedback loop by phosphorylating MDC1 and the
MRN complex to recruit and activate further ATM molecules, greatly amplifying the
signaling cascade. Additionally, ATM undergoes several phosphorylation and acetylation
modifications, including the autophosphorylation of particular residues (most notably,
serine 1981) that is essential for retention of ATM at DNA and prolonged DDR signaling
(195, 196).

1.5.3

Cell cycle checkpoints
The eukaryotic cell cycle is divided into four phases: gap (G1), synthesis (S), G2

and mitosis (M). During the G1 phase, the cell increases in size and begins synthesizing
RNA and proteins. During the S phase, genomic DNA undergoes replication to produce
an exact copy for the daughter cell. In G2, the cell continues to grow and produce enough
energy for division into two. Finally, during mitosis, the cell divides chromosomes,
separates into two daughter cells, and the cell cycle resumes. Cells that are not actively
cycling through these four phases are said to be in G0, a state that they may remain in
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transiently, or until their death. Cell cycle progression is largely controlled by the activity
of cyclins and cyclin dependent kinases (CDKs). Cyclins, small proteins that are
expressed and degraded in a coordinated matter as the cells transition between phases,
bind and activate the CDKs to induce phosphorylation of a number of cell cycle
regulatory proteins. The transition between each phase is tightly regulated and the cell
must ensure that the integrity of its DNA is not compromised prior to moving onto the
next phase, termed the G1/S, intra-S, G2/M or mitotic DNA damage checkpoints.
The G1/S transition (Figure 1-5A) is mediated by the CyclinD/CDK4/6 complex,
which phosphorylates a number of targets, including the Retinoblastoma protein (Rb), to
ultimately relieve inhibition on cell cycle promoting E2F transcription factors (201).
These factors create a positive feedback loop by promoting the activation of the
CyclinE/CDK2 complex, which phosphorylates more Rb, to activate more E2Fs and
drives transcription of genes required for the transition (201). The G1/S checkpoint is
essential for preventing cells from initiating DNA synthesis with damaged DNA. It is
initiated by the ATM-mediated phosphorylation of p53, the p53 inhibitor Mdm2, and the
kinase Chk2. Activated p53 upregulates the CDK inhibitor p21, which binds and inhibits
both the CyclinD/CDK4/6 and CyclinE/CDK2 complexes (201). In parallel, Chk2
induces the degradation of the phosphatase CDC25a, thereby preventing the removal of
inhibitory phosphates and maintaining an inactive CDK2 (201). This checkpoint is
extremely sensitive and can be initiated by a single DSB (202-204). At low doses it
functions to provide the cell with sufficient time for repair, which is estimated to be about
6 hours for a 1 Gy dose, as measured by the kinetics of H2AX phosphorylation (202204).
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Figure 1-5 DNA damage checkpoints.
(A) The transition from the G1 to S phase (boxed) is initiated by Cyclin D/CDK4/6
complex phosphorylation of the retinoblastoma protein (Rb), allowing the release of the
bound E2F transcription factors. The E2Fs stimulate a positive feedback loop by
initiating expression of the CyclinE/CDK2 complex, which phosphorylates more Rb, to
increase the pool of E2Fs and induce expression of genes necessary for S phase. The
G1/S DNA damage checkpoint is accomplished by two parallel mechanisms. (i) ATM
phosphorylates Mdm2 to allow the release of the transcription factor p53, and also
phosphorylates p53 to stimulate its transcriptional activity (activator phosphates in
green). p53 induces the expression of the cell cycle inhibitor p21 which binds and
inactivates both the CyclinD/CDK4/6 and CyclinE/CDK2 complexes. (ii) ATM
phosphorylates to activate the kinase Chk2, which subsequently phosphorylates the
phosphatase Cdc25a to trigger its degradation (inhibitory phosphates in red). Cdc25a is
required to remove inhibitory phosphates from the CyclinE/CDK2 complex, and so its
degradation keeps CyclinE/CDK2 in its inactive form. (B) The transition from the G2 to
M phase (boxed) is triggerered by the activity of the CyclinB/CDK1 complex. Wee1 and
Myt1 kinase dependent inhibitory phosphorylation keep this complex inactive, but
activity of the Cdc25a phosphatase removes this inhibition to induce G2/M transition.
The G2/M DNA damage checkpoint is achieved through two mechanisms similar to that
of the G1/S checkpoint. (i) ATM dependent upregulation of p21 to directly bind and
inhibit the CyclinB/CDK1 complex. (ii) ATM and Chk2 dependent degradation of the
cdc25a phosphatase to prevent removal of inhibitory phosphates from the CyclinB/CDK1
complex.
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Mitotic entry at the G2/M transition (Figure 1-5B) is driven by the activities of the
CyclinB/CDK1 complex. Prior to entry, the CyclinB/CDK1 complex is kept inactive by
Wee1 and Myt1 kinase mediated phosphorylation, but this inhibition is relieved by the
activities of the Cdc25 phosphatase. The G2/M checkpoint is initiated again through the
ATM dependent activation of p53 and Chk kinases. Similar to the G1/S transition, p21 is
upregulated to bind and inhibit the CyclinB/CDK1 complex, while Chk2 inactivates
Cdc25 to prevent the removal of inhibitory phosphates (205, 206). This checkpoint is
required to transiently arrest the cells to repair breaks occurring in G2 phase and prevent
the entry into mitosis with DNA damage. This process occurs rapidly, however, it does
not completely block progression, as there are several reports of cells still entering
mitosis in the presense of 10-20 DSBs (207-209).
Once the damage is repaired, cell cycle checkpoints are terminated and normal
cycling can resume. Although the mechanisms governing the resolution of damage
checkpoints are less well understood, it is known that the action of phosphatases play a
large role (210, 211). Examples of phosphatases demonstrated to counteract the DDR
activator kinases include Wip1, PP1, PP2A, PP4 and PP6, which remove the phosphates
on substrates such as ATM, checkpoint kinases, H2AX and DNA repair proteins,
rendering them inactive (212-216). The signaling pathways that drive the shift in balance
towards phosphatase over kinase activity remain to be established.

1.5.4

Senescence
Senescence can be defined as irreversible growth arrest to prevent the

proliferation of damaged cells (217). Senescent cells can be distinguished from other
non-dividing cells, such as quiescent and terminally differentiated cells, by
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morphological changes and the expression of several biomarkers. These include the
expression of cell cycle inhibitors, the absence of proliferation markers, constitutive
heterochromatin foci, and upregulation of the β-galactosidase enzyme (217). Initiation is
marked by the activation of p53, leading to the upregulation of several CDK inhibitors,
namely p16 (also known as INK4A), p15 (INK4B), p21 (WAF1) and p27, and promoting
the hypophosphorylation of the tumor suppressor Rb (198, 217, 218).
It is unclear what mechanisms induce senescence as opposed to transient cell
cycle arrest, as they are initiated by the same mechanisms, such as the p53-p21 and p16Rb pathways (217, 218). It is possible that the quick repair of DNA damage shuts down
signaling, whereas slow or incomplete repair results in prolonged signaling and an
eventual senescence phenotype. There is evidence that fibroblasts that have fully
activated the p16-Rb pathway are unable to resume growth, even after the inactivation of
p16, Rb and p53, indicating there is a point of no return in senescence activation,
however this point remains to be elucidated (219).

1.5.5

Apoptosis
The most drastic response to overwhelming DNA damage is the initiation of

programmed cell death, termed apoptosis. Apoptosis is a tightly regulated cascade,
triggered by either external (extrinsic pathway) or internal (intrinsic pathway) stimuli,
that converges upon a family of cysteine proteases (caspases) to cleave a broad range of
intracellular proteins and induce cell death (218, 220). Morphologically, this process
results in cellular shrinkage, chromatin condensation and fragmentation, membrane
blebbing and the formation of apoptotic bodies (220).
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The intrinsic apoptotic pathway mediates cell death in response to cellular
stresses, including DNA damage. The transcription factor p53 is a main regulator of this
process, and is activated following damage to transcriptionally upregulate genes encoding
apoptotic effectors (198, 220). Main targets of p53 in include the Bcl-2 family of
proteins, comprised of multidomain and BH3 domain-only members that regulate the
mitochondrial membrane permeability. Upon stimulus of the intrinsic pathway, p53
upregulates the pro-apoptotic Bcl-2 member, Bax, which induces mitochondrial
membrane permeability and allows the release of cytochrome c. This triggers the
activation of the intiator caspase, caspase 3, that in turn, cleaves to activate the effector
caspase, caspase 9, which is responsible for cleaving proteins involved in cell growth and
maintenance and ultimately causing cell death (218, 220).
There are additional p53-independent signaling cascades that are activated by
DNA damage and contribute to apoptosis. The JNK kinases (JNK1 and JNK2) are stressinduced kinases that execute its pro-apoptotic functions primarily through the activation
of the c-Jun, AP-1, and activating transcription factor 2 (ATF2) transcription factors
(221). Similarly, the mitogen activated protein kinase (MAPK) family member p38 is
often induced after DNA damage and upregulates the activities of ATF2, ATF3, cAMP
response element-binding protein (CREB) and C/EBP homologous protein (CHOP)
transcription factors (222). These transcription factors will subsequently regulate the
expression of vast array of proteins, including those of the Bcl-2 family, to promote cell
death (221, 222).

1.5.6

Ku in the DDR
There is some evidence that Ku is involved in the modulation of ATM activity
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following DNA damage. Ku appears to prevent ATM-dependent ATR activation, perhaps
acting as a signaling block to the HR pathway (223). Furthermore, Ku80 null cells were
shown to have increased S phase inhibition after DNA damage due to increased ATM
activity (224). We identified a specific residue in Ku70’s vWA domain, serine 155, that
when mutated to alanine results in decreased DNA damage signaling and apoptotic
activation after IR, despite having no impact on Ku’s ability to function in C-NHEJ (22).
These results suggest that in addition to its essential role in DNA repair, modification of
Ku also signals to the ATM dependent DDR cascade to regulate cell fate after DNA
damage. This is not entirely surprising as several other DNA repair factors (ex. Mre11),
have functions in both DNA repair as well as the DNA damage signaling cascade (225).
It is possible that Ku also has a dual role in the DNA damage response, first promoting
the repair by NHEJ, as well as relaying signals as to the completion, or lack thereof, of
DNA repair.
In addition to its impact on upstream DDR signaling, a number of studies have
implicated Ku70 as a direct inhibitor of apoptosis, through the binding and inhibition of
the pro-apoptotic factor Bax (226, 227). This interaction is proposed to be modulated by
various mechanisms, including protein-protein interactions and post-translational
modification of Ku. Some examples of protein interactions include the binding of Ku70
to NBS1 and a cleavage product of cyclin E, both of which were suggested to inhibit the
binding of Ku70 to Bax and promote apoptosis (228, 229). The acetylation of Ku70 is
also suggested to negatively regulate the Ku70-Bax interaction. Ku70 is acetylated in the
C-terminal linker domain on eight lysine residues between K539 and K556 and alanine
substitution of these residues decreased Bax-dependent apoptotic activation (31). This
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acetylation is mediated by CREB-binding protein (CBP) and P300/CBP-associated factor
(PCAF) while deacetylation is controlled by histone deacetylase (HDAC) and sirtuin
(SIRT) deacetylase enzymes (31, 230, 231). There is some evidence that Ku may have
deubiquitination activity, as it has been proposed to promote the deubuquitination of Bax,
and another anti-apoptotic regulator of Bax, Mcl-1 (226, 232). Overall, there are several
unanswered questions regarding the interaction with Ku70 and Bax. Many studies have
suggested that this interaction occurs in the absence of Ku80, despite the fact that there is
little evidence that the Ku subunits exist as monomers. Furthermore, Ku is predominantly
a nuclear protein but Bax is largely cytoplasmic in its inactive form and then translocates
to the mitochondria during apoptotic activation (233). The regulatory mechanisms that
would allow a subset of Ku70 monomers to remain in the cytoplasm bound to Bax
remain to be elucidated.

1.5.7

Aurora Kinases
The Aurora kinases are a family of serine/threonine kinases with a well-

established role in promoting cell cycle progression (234). Mammalian genomes encode
for three members, Aurora A, B and C, which differ in their size, function and subcellular
localization. All members can be divided into three general domains: a well conserved
central catalytic domain, C-terminal region containing a D-box motif required for
degradation, and a diverse N-terminal region largely utilized as a regulatory domain
(234). Aurora A and B are most similar in their structure and ubiquitous expression
pattern, however their cellular roles vary due to their differing localization. Aurora A
promotes mitotic entry and spindle assembly, while Aurora B is involved in the spindle
assembly checkpoint, kinetochore attachment, chromatin modification and cytokinesis
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(234). Although their roles in mitosis are well described, increasing evidence suggests
that the both Aurora A and B also participate in the G1/S and G2/M transitions (235,
236). These proteins are often found upregulated in cancers and have subsequently
become the target of several small molecule inhibitors to utilize in cancer treatment (237,
238).
The regulation of aurora kinases is tightly controlled by a number of different
mechanisms. Ultimately, the activation is achieved through the autophosphorylation of a
threonine residue in the activation loop of the catalytic domain. However, many
activating cofactors are involved that bind either the catalytic domain or the N-terminal
regulatory region and allow for the specific activation of kinase activity at the correct cell
cycle phase and subcellular localization (239). Aurora B is the catalytic member of the
mitotic chromosomal passenger complex (CPC) and requires the binding of the other
regulatory complex members (INCENP, Survivin and Borealin/Dasra B) for full
activation and localization to the centromere (240). Protein binding either induces
conformational changes in Aurora to promote catalytic activation, or the regulatory
subunits promote Aurora B clustering and subsequent autoactivation. Cofactors also bind
and inhibit Aurora activity, such as the PP1 and PP2A phosphatases, that remove
activating phosphatases to render it inactive (241, 242).
Not surprisingly, as kinases that promote cell cycle progression, Aurora kinases
are found inhibited after the introduction of DNA damage (243, 244). Emerging evidence
suggests that this regulation is due to interactions with DDR and DNA repair factors.
Aurora B has been shown to interact with, and be inhibited by, the A-NHEJ factor PARP1, while the HR factor BRCA2 has been demonstrated to promote Aurora B degradation
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(244, 245). There are also indications of a reciprocal regulation of DDR factors by
Aurora kinases. Aurora B has been shown to phosphorylate ATM, while Aurora A
regulates BRCA1 and p53. Overall, given the strong interest in targeting Aurora kinases
for cancer treatment, a clearer understanding of how Aurora kinases are regulated after
DNA damage is required.

1.6
1.6.1

Ku in Disease
Immune system disorders

The vertebrate immune system utilizes Ku and C-NHEJ to repair physiological
DSBs generated to create immune system genetic diversity. Recombination of the V, D,
and J segments of immunoglobulins (Ig) in lymphoid cells and class switch
recombination of the T-cell receptor genes in mature T cells allows for the recognition of
a wide variety antigens, which results in an adaptive immune response (246). The exons
of the Ig genes are flanked by recombination-signal sequences that are recognized by the
recombination-activating gene (RAG) complex to produce a blunt ended DSB at the
signal sequence and a closed hairpin at the coding sequence. This structure is then
processed and resolved by the C-NHEJ machinery (246).
Ku70 and Ku80 knockout mice display many immune system abnormalities
including B cell developmental arrest, T cell arrest, and failed lymphocyte differentiation
following γ-irradiation (67, 247-249). Humans and mice suffering from genetic defects in
V(D)J recombination present with a severe combined immunodeficiency (SCID)
phenotype resulting in severe infections and poor prognosis. There are several
characterized human disorders with various degree of SCID phenotype that have been
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linked to mutations in NHEJ factors, such as DNA Ligase IV, Artemis, and XLF, as well
as the other DSB repair pathway and DDR factors (250-253). Interestingly, only a few
individuals have been reported to have genetic defects in the DNA-PK complex,
however, all presented mutations occurred in the DNA-PKCS subunit, and thus far, no
disorder linked to Ku mutations has been identified (254, 255). It is currently unknown
whether mutations in Ku are better tolerated in humans, or in the contrary, whether
deleterious Ku mutations are lethal in humans.

1.6.2

Aging
Aging is the progressive degeneration that occurs at the cellular and organismal

level. One of the observed phenotypes of Ku deficient mice is increased aging and
senescence (249, 256-258). Mice deficient in one Ku subunit have one-third the lifespan
of their wildtype counterparts, partially in due to an early onset of the phenotypic
symptoms of aging (259). There is evidence that C-NHEJ declines during the aging
process, with lower efficiency observed in aging rodents, and in Alzheimer’s patients, so
the loss of NHEJ in Ku deficient mice could be contributing to the aging process (260262). Furthermore, as previously described, Ku deficient mice and cells exhibit shortened
telomeres as well as other telomere abnormalities. Shortened telomeres have been linked
to increased aging and senescence, due to increased genomic instability leading to cell
cycle arrest, so this could also be contributing to the aging phenotype observed in Kudeficient mice (263, 264).

1.6.3

Cancer
A common characteristic amongst human tumors is genomic instability (265).

Cells defective in DSB repair are predisposed to chromosome translocations and gene
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amplifications, potentially leading to the activation of oncogenes and tumourigenesis.
Through its role in C-NHEJ, Ku functions as a cancer caretaker gene, promoting genomic
integrity and preventing tumourigenesis. Ku knockout mice show increased chromosomal
breakage, translocations and aneuploidy (249, 256, 258, 259). These mice display slightly
increased cancer incidence as compared to controls, however this is mostly restricted to
lymphomas (249, 256, 258, 259). Together with a p53 deficiency that impairs control of
proliferation, Ku80 deficient mice show early onset tumour formation and further
increased incidence of T and B cell lymphomas (68). This suggests that Ku mutations can
be oncogenic when accompanied by a mutation in a tumor suppressor gene.
The expression of Ku has been frequently found deregulated in tumour samples
and its expression level has been proposed as a marker of predicting patient response to
radiation therapy and survival (266-271). The exploitation of genetic defects in DNA
repair and DDR factors have long been employed in cancer treatment (272). As
previously mentioned, Ku and DNA-PKCS deficient cell lines are sensitive to radiation
and chemotherapeutic drugs, and therefore would make them potential druggable targets
in cancer treatment. There are a few examples of strategies to target Ku specifically,
including a subunit dimerization interference using a peptide, downregulation by RNAi
and small molecule inhibition (273-276). The therapeutic potential of targeting the
Ku70/Bax interaction to activate apoptosis in cancer has been explored through creation
of Bax inhibiting peptides derived from the Ku70 sequence and promoting Ku70
acetylation in vivo through deacetylase inhibitors (277-279). A more commonly
employed strategy to target the DNA-PK complex however, is to modulate the kinase
activity of DNA-PKCS with small molecular inhibitors, as DNA-PKCS expression is
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frequently found upregulated in tumours (280).

1.7

Scope of thesis

The cellular response to DSBs is a tightly controlled process with the ultimate
goal of repairing the DNA damage, but also protecting the overall health of the organism.
Amongst proteins involved in the DDR, there are several examples of DNA repair
proteins performing dual roles in both repair and maintaining the signaling cascade. For
example, the MRN complex has a mechanistic role in the HR DSB repair pathway, but
also is integral for the activation and propagation of ATM signaling. We have identified a
similar role Ku, which has a well-established role as the DNA binding component of the
NHEJ repair pathway, and for which we now propose a novel role for Ku in the signaling
to DDR in the case of unsuccessful DNA repair.
The focus of this work is the Ku70 vWA domain, a conserved protein-protein
interaction domain, for which the function in DNA repair has remained uncertain. We
begin by investigating the requirement for different regions of the Ku70 vWA domain in
response to IR (Chapter 2). We show that helix 5, particularly the residues D192/D195,
are integral for Ku’s DNA repair function. Mutation of these residues severely
compromises cell survival in response to IR and dramatically decreases DNA repair
efficiency. In contrast, the loop region between helix 4 and 5, particularly the residue
S155, is required for activation of the DDR after IR. Substitution of this residue to
alanine surprisingly increased survival in response to IR. Further analysis indicated that
mutation of this residue conferred decreased activation of DDR signaling markers and
apoptosis, indicating that mutation of this residue was preventing the DDR from
signaling to the apoptotic machinery. Overall, this chapter established an important role
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for the Ku70 vWA domain in the response to DSBs.
Next, we went on to further characterize the role of S155 in the DDR (Chapter 3).
We hypothesized that this residue was a phosphorylation site and used mass spectrometry
analyses to observe phosphorylation after IR. Expression of a phosphomimetic
substitution at this site, S155D, induced constitutive activation of DDR and cell cycle
arrest at both the G1/S and G2/M checkpoints. Through a general screen of interacting
factors, we identified the region surrounding S155 as contributing to the binding and
inhibition of the cell cycle kinase Aurora B. In wild type cells, we determined that Ku
does not bind Aurora B constitutively, but after IR, they complex to inhibit Aurora B
activity and induce cell cycle arrest. Altogether, we have characterized a novel
phosphorylation event in the Ku70 vWA domain that relays DNA repair signals to the
DDR to carry out cell fate decisions.
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Chapter 2

2

Ku regulates DNA repair and the DNA damage
response through the Ku70 vWA domain

2.1 Introduction
One of the most dangerous forms of DNA damage is the DNA double-strand break
(DSB), which can lead to aberrant genomic rearrangement if not repaired properly (1, 2).
In eukaryotic cells, DSBs trigger signaling pathways that induce cell cycle checkpoints
and alter gene transcription allowing DNA integrity to be re-established through the
action of repair complexes (3-6).
The DNA damage response (DDR) pathway is initiated by a phosphorylation cascade
that triggers chromatin modifications which enhance accessibility of the broken DNA to
repair factors and promote the subsequent accumulation of DDR factors into foci at the
site of damage (4, 7). The Mre11-Rad50-NBS1 (MRN) complex immediately binds the
DSB, independently of other factors (8), functioning to recruit the serine/threonine (S/T)
phosphoinositide-3-kinase (PI3K) family member ATM (Ataxia Telangiectasia Mutated),
an essential regulator of the DNA damage response that is responsible for many
phosphorylation events at the site of DNA damage (9, 10). An important signal
amplification step involves the ATM phosphorylation of the histone variant H2AX to
create a platform to which other DDR proteins are able to bind (11). ATM activates
signaling cascades that trigger the activation of cell cycle checkpoints leading to cell
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cycle arrest through phosphorylation of several substrates including p53, MDC1, BRCA1,
Chk1 and Chk2. ATM also contributes to the establishment of apoptotic pathways (9).
Two main pathways function to repair DSBs, homologous recombination (HR) which
uses a homologous chromosome or sister chromatid as template to repair the broken
DNA, and non-homologous end-joining (NHEJ), which simply re-ligates the two broken
ends together (2). In mammals, NHEJ is the predominant DSB repair pathway,
functioning throughout the cell cycle, and exclusive to the G1 and S phases (12, 13).
NHEJ also mediates the rejoining of programmed breaks generated in V(D)J
recombination during B and T cell maturation (12, 13). NHEJ can be subdivided into two
sub-pathways, the core or “classical” NHEJ pathway (C-NHEJ) which represents the
main end-joining activity in the cell, and “alternative” NHEJ activities (A-NHEJ)
consisting of microhomology-mediated repair that function as backup pathway(s) to join
DSBs (2, 12, 14).
The C-NHEJ complex in higher eukaryotic cells consists of DNA-dependent protein
kinase (DNA-PK), composed of the Ku heterodimer and DNA-PK catalytic subunit
(DNA-PKcs), Artemis, a DNA processing enzyme, a DNA ligase complex,
XRCC4/DNA ligase IV and a recently identified factor called Cernunnos-XLF (12, 13,
15). Other accessory factors, including polynucleotide kinase (PNK) and DNA
polymerases µ and λ have been implicated in some aspects of C-NHEJ (12, 13).
Ku is the DNA-binding component of the C-NHEJ repair machinery. Upon
recognition and binding to the broken DNA end Ku recruits DNA-PKcs to form the
active protein kinase complex DNA-PK (12, 13). DNA-PKcs is a large (p450) S/T kinase
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that is a member of the PI3K kinase group that includes ATM, ATM-related (ATR) and
mammalian target of rapamycin (mTOR) (16-18). The importance of DNA-PK in
maintaining genomic integrity is underscored by the profound immunodeficiency,
radiosensitivity and prevalence of tumours in mice lacking any of the 3 subunits (19-22).
However, DNA-PKcs knockout mice display milder defects than Ku-/- mice, suggesting
that Ku has additional functions independent of DNA-PKcs (22, 23). Besides DNA end
recognition, Ku appears to protect broken DNA from aberrant nucleolytic processing
(24). Ku has also been shown to bind to telomeres and to function in telomere
maintenance, notably by anchoring telomeres to the nuclear periphery, contributing to
telomeric silencing and preventing telomere shortening (24, 25) .
In addition to its main function in DNA repair, several reports have suggested that
DNA-PK may also be involved in signaling to regulate specific aspects of the DDR.
DNA-PK participates in replication protein-A2 (RP-A2) and nuclear factor-κB (NF-κB)
phosphorylation in response to DNA damage and also contributes to the modification of
histone H2AX (reviewed in (17, 26)). Roles for Ku in signaling to the apoptotic
machinery have also been documented (17).
Aside from a recently identified end-processing activity (27), much of Ku’s function
appears to be mediated by protein-protein interactions with other factors. A number of
proteins interact with Ku, including C-NHEJ core proteins and factors implicated in the
DDR, in telomere maintenance, transcription and replication (26, 28). Within the
mammalian C-NHEJ complex, interaction of Ku with XRCC4/DNA ligase IV is required
to recruit the complex to DNA and to stimulate the ligase activity (29, 30). Yeast Ku also
interacts with factors of the RSC complex that mediates ATP-dependent chromatin
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remodelling in yeast (31). Interaction with DNA repair and damage-response factors
Mre11, Werner and PARP have also been documented (26, 28).
Ku is a heterodimer of two proteins, Ku70 and Ku80 that form a complex that is
conserved throughout evolution both structurally and functionally (24, 28, 32, 33). Ku
homologs are found from bacteria to man (33). The two subunits of Ku in eukaryotes
feature three structurally similar domains: an amino-terminal α/β domain, a central βbarrel domain and a α-helical carboxy-terminal arm that come together in the
heterodimer to form a quasi-symmetrical ring structure that envelopes up to two helical
turns of DNA end as seen in the crystal structure (32). The Ku70 carboxy-terminal
domain sequence shows similarities with SAP domains that are involved in DNA binding
(32, 34), whereas the Ku80 C-terminal domain, forms a globular structure with similarity
to protein domains involved in protein-protein interactions (35, 36). The amino-terminal
domains of Ku70 and Ku80 (α/β domains (32)) share similarity with von Willebrand
factor A (vWA), a domain that mediates protein-protein interactions (32, 33, 37). The
vWA domains of Ku fall into the “ancient conserved vWA proteins” that comprises a
group of evolutionarily conserved intracellular proteins (37). However, while Ku
interacts with many proteins, few have been mapped to the vWA domains (13, 24, 26,
28). Site directed mutagenesis of the Saccharomyces cerevisiae YKU80 and YKU70 genes
identified that α-helices on the surface of the vWA domain confer different Ku functions
(38). The Yku80 α-helix 5 is critical for telomeric functions, while Yku70 α-helix 5 is
required for C-NHEJ. This likely results from differences in the orientation of the two
vWA domains, the Ku70 vWA domain facing outwards in close proximity to the DNA
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end, whereas the Ku80 vWA domain faces inwards, thus facilitating telomeric functions
(32, 38).
In mammals, very little is known about the precise function of the Ku70/Ku80 Nterminal vWA domains. In this study, we introduced point mutations in various regions
of the Ku70 vWA domain with the intent of identifying structural determinants that direct
Ku function in response to DNA damage (Fig. 1). Mutation of Ku70 vWA α-helix 5
residues (D192A/D195R) resulted in a sharp decrease in survival. These substitutions,
previously shown to confer a DNA repair defect in yeast (38), markedly impaired the
DNA repair function of Ku in mouse embryonic fibroblasts (MEFs), suggesting that the
function of these residues is conserved between yeast and mammals. Unexpectedly, the
mutagenesis of residues adjacent to α-helix 4 (S155A/D156A) resulted in increased
survival following ionizing radiation (IR) treatment. C-NHEJ appeared unaffected, but a
marked decrease in the activation of apoptosis and alterations in the DNA damage
signaling response as well as in the transcriptional profile of gene expression following
DNA damage were identified. In particular, this mutation affected an activating
transcription factor 2 (ATF2)-dependent transcriptional pathway that modulates several
genes implicated in the activation of apoptosis. The D192A/D195R survival defect was
rescued by introducing the S155A/D156A substitution, inferring that separate regions of
the Ku70 vWA domain confer two different Ku functions in response to DNA damage.
Further, S155 was identified as the critical residue regulating cell survival. Thus,
importantly, the defects resulting from these mutations suggest that the N-terminal vWA
domain of Ku70 is implicated in the activation of apoptotic pathways by linking signals
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of DNA repair completion (or lack thereof) to the signaling machinery that controls the
activation of cell death pathways.

2.2
2.2.1

Material and Methods
Plasmid expression constructs

Ku70 human cDNA was cloned from the BamHI site in pEGFP Ku70 (39) into the
HpaI site of pMSCVpuro retroviral vector (Clontech). Ku70 point mutations were
introduced by site directed mutagenesis using Pfu polymerase (Stratagene) with primers
bearing the targeted point mutations (primers are listed in Table S3 in the supplemental
material). All mutations were confirmed by sequencing. pGL3-Promoter and pRL-SV40
plasmids are from Promega.

2.2.2

Cell culture treatments

Ku70-/- MEFs were obtained from S. Matsuyama (Case Western, Cleveland (40)). All
cells were cultured in high glucose Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) at 37°C in 5% CO2.
pMSCV vectors containing wild-type and mutant Ku70, as well as the empty
pMSCVpuro vector were transfected via calcium phosphate into the Phoenix Ampho
retroviral packaging cell line. The media-containing virus was collected 48 hours later
and used to infect Ku70-/- MEFs. Twenty-four hours post infection the media was
replaced with 2.5µg/ml puromycin containing media to select and maintain cells infected
with the pMSCV vector. Cells were maintained as a pool for all subsequent experiments.
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For irradiation experiments, cells were plated the night before at 50-70% confluency.
Irradiations were performed with a Faxitron RX-650 at a dose rate of 1.42 Gy/min.

2.2.3

Extracts and western blot analyses

Whole cell extracts were prepared as described (41). Nuclear Extracts were prepared
as described (42). For Western blot analysis, extracts were resolved by SDS PAGE
(either 8% or 10%), transferred onto a PVDF membrane and hybridized with the
following antibodies:, Ku70 (N3H10, Neomarkers), Ku80 (M-20, Santa Cruz), β-actin (I19, Santa Cruz), GADD153/CHOP (F-168, Santa Cruz), ATF3 (C-19, Santa Cruz),
PCNA (clone PC-10, Millipore), 69/71 phospho ATF2 (Cell Signaling), ATF2 (N-96,
Santa Cruz).

2.2.4

Clonogenic survival assays

Cells were plated in triplicate at single cell density, irradiated 6 hours later at various
doses of IR and then incubated for 7 days. The plates were washed with PBS and stained
with 0.5% crystal violet in 20% methanol. Colonies were counted and survival was
assessed by calculating the ratio of colony number on the irradiated plates over the
unirradiated controls.

2.2.5

Caspase assays

Cell extracts were prepared in Lysis buffer (1mM KCl, 10mM HEPES (pH 7.4),
1.5mM MgCl2, 1mM DTT, 1mM PMSF, 5µg/ml leupeptin, 2µg/ml aprotinin, and 10%
glycerol). Caspase activity was measured in caspase assay buffer (25 mM HEPES, pH
7.4, 10 mM DTT, 10% sucrose, 0.1% CHAPS containing 10 µM caspase-3 substrate, Nacetyl-Asp-Glu-Val-Asp-(7-amino-4trifluoromethyl-coumarin) (DEVD-AFC, BIOMOL
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International)). The fluorescence produced by DEVD-AFC cleavage was measured on a
SpectraMax M5 fluorimeter (excitation 400 nm, emission 505 nm) over a 2 h interval.
Caspase activity was calculated as the ratio of the fluorescence output in treated samples
relative to corresponding untreated controls.

2.2.6

Pulsed-field gel electrophoresis

One day prior to irradiation, 3.5 million cells were seeded onto a 10 cm plate.
Following 40 Gy of IR or mock treatment, cells were harvested into agarose plugs using
the Bio-Rad CHEF Genomic DNA Plug Kit. Agarose plugs were run on a 0.8% gel using
the Bio-Rad CHEF-DR II system (200-500s switch time, 120° angle, 3V/cm, 48 hours).
The gels were stained with ethidium bromide, images captured using a BioRad
ChemiDoc and ImageLab software and staining was quantified using ImageJ. The
fraction released (fraction of activity released, FAR) corresponding to unrepaired DNA
was calculated by calculating the ratio of the DNA migrating below the plug over the
total DNA loaded (DNA remaining in the plug and fraction entering the gel).

2.2.7

Plasmid repair luciferase assays

The pGL3-Promoter luciferase reporter plasmid was digested with Bgl II, which cuts
between the promoter and the luciferase coding region. pMSCV infected MEFs were
transfected with 750 ng of linearized PGL3-Promoter and 5 ng of pRL-SV40 in 12 well
plates using Fugene6 (Roche) following the manufacturer’s instructions. Forty-eight
hours post transfection the cells were harvested in 0.3 ml 1x passive lysis buffer
(Promega) and luciferase assays were performed with 30 µl of extract with the Promega
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Dual-Luciferase Reporter Assay System (50 µl of both LAR II and Stop & Glo®
reagents) using an Orion II luminometer (Titertek-Berthold).

2.2.8

Immunofluorescence
One day prior to irradiation, cells were seeded at 60-80% confluence on 10 mm

glass coverslips. At the given time points post irradiation, cells were washed in cold PBS
and fixed in 3% paraformaldehyde. Cells were permeabilized in 0.5% Triton-X and
blocked in 5% FBS, followed by incubation with the primary antibodies, either phosphoserine 139 H2AX antibody (20E3, Cell Signaling) or ATF2 (C-19, Santa Cruz), or 69/71
phospho ATF2 (Cell Signaling). Slides were then incubated with an anti-rabbit Alexa 497
secondary antibody (Invitrogen). Coverslips were mounted onto glass slides using
ProLong Gold containing DAPI (Invitrogen). Cell pictures were taken with an Olympus
BX51 microscope at 40x magnification and the Image-Pro Plus software (Media
Cybernetics, Inc.). For g-H2AX and phospho-ATF2, pixel density was measured with
ImageJ software and used as a measure of foci content per picture. DAPI nuclei staining
were used for cell counting and the pixel density was averaged per cell for approximately
500 cells. For quantification of ATF2 foci, all pictures were set to an equal contrast
threshold on ImageJ and cells were scored positive if containing at least one focus.

2.2.9

Reverse transcriptase (RT-qPCR)

Total RNA was isolated using the Qiagen RNeasy RNA Extraction kit. RNA (2 µg)
was reverse transcribed with the Superscript II cDNA kit (Invitrogen). Quantitative PCR
was performed using Bio-Rad MyiQ single-colour real-time PCR detection and Bio-Rad
IQ SYBR green mix. Primers are listed in Table S3 in the supplemental material. Relative
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quantification of specific gene expression was determined by the ΔΔC(t) method, with
the target gene C(t) values normalized to that of the beta-2-microglobulin control. Change
of gene expression in irradiated samples was calculated relative to the unirradiated
controls.

2.2.10

Sequence alignments

Sequences were obtained from the NCBI database and aligned using MUSCLE
software (43). Percent identity calculations were performed using Jalview software.

2.2.11

Statistical analyses

Differences between two groups were compared using an unpaired two-tailed ttest and analysis of variance (ANOVA) was used when comparing multiple groups.
Results were considered significant when P<0.05.

2.3
2.3.1

Results
Identification of Ku70 mutations that impair survival in
response to IR

In order to investigate the contribution of the Ku70 vWA domain in Ku70’s function
in the response to DSBs, several point mutations were produced in the human Ku70 vWA
domain. These mutations targeted residues located on the solvent exposed surface of the
protein and showing various degrees of conservation across Ku70 homologs (Figure 2-1).
For instance, residues in Ku70 α-helix 5 previously involved in DNA repair in yeast are
fairly well conserved (Figure 2-1A) (38). In contrast, α-helix 3 is much less conserved
(Figure 2-1A). We produced five different Ku70 mutations: two mutations in α-helix 3,
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Figure 2-1 Generation of Ku70 vWA domain mutants
(A) Sequence alignment of the Ku70 N-terminal vWA domain (α-helices 3 to 5) from a
selection of Ku70 eukaryotic homologs. The position of the vWA domain α-helices is
indicated at the top. Conservation between species of the residues within α-helices 3 to 5
is highlighted according to percent identity (PID) (light grey >40%, dark grey >60%, and
black >80% PID). The residues mutated in this study are boxed and the substitutions
introduced are indicated below the alignments. (B) Space-filling representations of the
human Ku dimer structure bound to DNA (32) (PDB ID: IJEY depicted in PyMol). Top,
front view of the Ku dimer (facing the DNA end). The Ku70 vWA domain E145/W148,
S155/D156 and D192/D195 residues are highlighted in black and their position is
indicated. DNA is represented as a black helix. Below, side view of the Ku dimer (DNA
end to the left). The position of the Ku70 vWa domain K114/L117 and K129/D133
residues is shown.
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one in α-helix 4, one in α-helix 5, and one in a loop region bordering α-helix 4
(S155A/D156A) (Figure 2-1B). At each location, we substituted 2 amino acids to
maximize the likelihood of disrupting a protein interacting surface. Wild-type human
Ku70 as well as the various mutant human Ku70 cDNAs were stably introduced into
Ku70-/- immortalized MEFs via a murine stem cell virus construct. To determine whether
the mutations interfered with Ku’s function in response to IR, we measured the
radiosensitivity of MEFs expressing wild-type or mutant Ku70 at various doses of IR
(between 2 and 10 Gy) using a clonogenic assay. Cells lacking Ku70 are severely
deficient in DSB repair and therefore have very low survival following treatment with IR
(44). Consistent with previous reports (44, 45), the re-expression of human Ku70 in the
Ku70-/- MEFs restored wild-type MEF survival in response to IR (Figure 2-2A). Western
blot analyses indicated that the level of Ku70 restored was similar to that in wild-type
cells (Supplementary Figure 2-1). Also, we verified that the expression of Ku80, which is
reduced to undetectable levels in the absence of the Ku70 subunit was re-established
upon expression of the human Ku70 construct (Figure 2-2D and 2-3D).
MEFs expressing α-helix 3 and α-helix 4 Ku70 mutant constructs produced survival
curves not significantly different from wild-type, therefore suggesting that these
substitutions do not interfere with Ku’s role in response to IR (Supplementary Figure 22). An α-helix 5 mutation (D192A/D195R) was designed based on the previously
identified DNA repair defect associated with the mutation of the corresponding residues in
yeast Ku70 (38). The Ku70 D192A/D195R expressing cells showed a dramatic decrease
in survival following IR treatment, displaying a survival curve that more closely
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Figure 2-2 Analysis of cell survival properties of Ku70−/− MEFs expressing Ku70
bearing substitutions in the N-terminal vWA domain.
(A) Re-expression of human wild-type Ku70 via retroviral infection restores wild-type
survival levels of MEFs following ionizing radiation. Clonogenic survival of MEFs wildtype (Ku70+/+), Ku70-deficient (Ku70-/-) or Ku70-/- expressing empty vector (pMSCV) or
Ku70 cDNA (Ku70 pMSCV) was tested at the IR doses indicated. Results are the means
of three separate experiments performed in triplicate with error bars representing the
standard deviation (SD). Error bars are included for all data points but may not be visible
when smaller than symbol size. (B) Ku70-/- MEFs expressing Ku70 mutant bearing
substitutions D192A/D195R exhibit radiation sensitivity. Clonogenic assay was done as
in A with Ku70-/- MEFs expressing Ku70 wild-type (WT), Ku70 with substitutions
(D192A/D195R) or empty vector (pMSCV).

(C)

MEFs expressing Ku70 with

S155A/D156A substitutions show increased survival following IR. Clonogenic assay
results are presented as in A. Error bars represent the SD. (D) Representative western
blot analysis of Ku70-/- MEFs or Ku70-/- MEFs expressing wild-type Ku70 (WT) and
Ku70 S155A/D156A. The blot was analyzed with antibodies to Ku80, Ku70 and PCNA,
as indicated. The star (*) indicates the position of a non-specific band migrating above
Ku80.
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matched that of the Ku70-/- cells than that of wild-type (Figure 2-2B). For example at 4
Gy, 34% of Ku70 wild-type expressing MEFs formed colonies, versus 4.5% of cells
expressing empty vector and 10% of Ku70 D192A/D195. At 6 Gy, 20% of wild-type
cells survived versus 4% in Ku70 D192A/D195R and 1.5% in cells expressing empty
vector. This suggests that these residues may be functionally conserved between yeast
and human. Intriguingly, a Ku70 mutant bearing alanine substitutions of residues S155
and D156 located in a loop region between α-helices 4 and 5 consistently conferred a 4050% increase in survival compared to wild-type (at 4 Gy, 60% versus 33% and at 6 Gy,
30% versus 19%, Figure 2-2C). This was unexpected, and as the expression of this
mutant was similar to that of Ku70 wild-type (Figure 2-2D), suggested that the mutation
enhanced viability in response to IR.

2.3.2

S155A/D156A does not affect DNA repair efficiency

Since Ku’s prominent documented function is to recruit DNA repair factors to DSBs
and promote C-NHEJ, we first considered the possibility that the increase in survival
conferred by the Ku S155A/D156A mutant was due to an improved capacity for DNA
repair. To test this possibility, we employed pulsed-field gel electrophoresis (PFGE) to
analyze DNA repair. The analysis was performed with samples processed immediately
following IR, to measure the total amount of genomic DNA breakage, 2 hours later, when
DNA repair is on-going and then 6 hours after IR treatment, at which time most DNA
breaks are already repaired (46, 47). Comparison of Ku70 wild-type and Ku70
S155A/D156A mutant cells revealed no significant differences in their abilities to repair
genomic DNA damaged by IR (Figure 2-3A). To confirm this result, an in vivo plasmid
repair assay was employed, which measures the cell’s ability to recircularize a transfected
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Figure 2-3 The Ku70 S155A/D156A mutation does not affect DNA repair.
(A) The S155A/D156A mutation does not interfere with the repair of IR induced
genomic DNA damage. PFGE analysis of genomic DNA from Ku70-/- MEFs expressing
Ku70 wild-type (WT), Ku70 S155A/D156A or empty pMSCV either untreated (control)
or immediately after IR (0h), 2h or 6h following IR treatment. For all samples, FAR
(fraction of activity released) was averaged from 3 independent experiments with error
bar representing SEM. (B) The Ku S155A/D156A mutation does not interfere with the
repair of extrachromosomal DNA breaks. Ku70-/- MEFs expressing Ku70 wild-type
(WT) mutant S155A/D156A or empty vector (pMSCV) were transfected with a
linearized pGL3-Promoter plasmid and control pRL-SV40 plasmid and assayed for
luciferase activity 48 hours later. Data represents the average firefly luciferase values
normalized to the renilla luciferase for 3 separate experiments with error bars
representing SD (*P <0.01).

(C)

Ku70 S155A/D156A mutation rescues the IR

sensitivity conferred by the D192A/D195R substitution. Clonogenic survival assay of
Ku70-/- MEFs expressing Ku70 wild-type (WT), Ku70 bearing the substitutions
D192A/D195R or the double mutant D192A/D195R, S155A/D156A. Results are
averaged from 3 experiments and the error bars represent the SD. (D) Western blot
analysis of Ku70-/- MEFs with empty vector (pMSCV) or Ku70-/- MEFs expressing wildtype Ku70 (WT) and Ku70 mutants as indicated. The blot was analyzed with antibodies
to Ku80, Ku70 and actin. (E) Ku70 S155A/D156A substitutions do not rescue the DNA
repair defect conferred by the Ku70 D192A/D195R mutation. PFGE analysis was done as
in A with genomic DNA from Ku70-/- MEFs expressing Ku70 wild-type (WT),
D192A/D195R, the double mutant D192A/D195R, S155A/D156A or empty pMSCV
either untreated (control) or immediately after IR (0h), and 6h following IR treatment.
FAR was averaged from 3 independent experiments with error bar representing SEM (*P
<0.05).
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linearized luciferase expression plasmid by measuring luciferase activity. Ku wildtypeand Ku70 S155A/D156A cells showed no significant difference in their ability to
repair restriction enzyme cut extra-chromosomal plasmid DNA (Figure 2-3B), suggesting
that the mutated residues did not enhance the DNA repair function of Ku. To substantiate
the potential for the Ku S155A/D156A mutation to increase survival independent of
DNA repair, we tested whether this mutation could rescue the survival defect conferred
by a Ku repair mutation. To this end, we introduced the D192A/D195R substitution in αhelix 5 in the Ku70 S155A/D156A construct. The survival of cells expressing the double
mutant Ku70 S155A/D156A, D192A/D195R was completely rescued (Figure 2-3C),
suggesting that mutation of the S155/D156 residues can compensate for the defects
imparted by a DNA repair deficiency. To confirm this result, we analyzed DNA repair in
cells expressing Ku70 D192A/D195R versus the double mutant Ku70 S155A/D156A,
D192A/D195R using PFGE (Figure 2-3E). As expected, Ku70 D192A/D195R expressing
cells displayed a marked repair defect not statistically different than that of the Ku70deficient cells. A similar repair defect was observed in cells expressing the Ku70
S155A/D156A, D192A/D195R substitutions, providing evidence that S155A/D156A
substitutions do not affect Ku’s function in DNA end-joining and confer a survival
advantage that is independent of DNA repair.

2.3.3

Ku70 S155A/D156 mutant cells display decreased activation
of apoptosis

Since the S155A/D156A mutation did not affect DNA repair, it suggested the
possibility that it may interfere with DNA damage response pathways and prevent the
execution of apoptosis. To determine whether apoptosis was affected in Ku70
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S155A/D156A expressing cells, we tested the endpoint of apoptosis, using a caspase-3
assay. While wild-type Ku70 MEFs showed a strong caspase-3 activity at 48 and 72
hours post-IR, the mutant cells displayed significantly lower caspase-3 activity, and
therefore decreased apoptotic activation (Figure 2-4A). We then compared the ability of
Ku70 wild-type and Ku70 S155A/D156A expressing cells to form γ-H2AX foci, an early
marker of the DNA damage response (46). Ku70 S155A/D156A cells showed no
significant difference in basal foci levels in absence of IR treatment, whereas, Ku70-/cells had increased γ-H2AX foci levels indicative of unrepaired endogenous DSBs. Early
foci formation 1 hour following IR treatment was again similar in Ku70 wild-type and
S155A/D156A-expressing cells, suggesting that the mutation did not interfere with the
initial phosphorylation events. However Ku70 S155A/D156A cells displayed persistent
foci 24 hours following IR compared to Ku70 wild-type cells (Figure 2-4B) suggesting
an abnormally prolonged DNA damage response. Altogether, these results suggested that
the mutation interfered with the activation of apoptosis and resulted in a persistent DNA
damage response.

2.3.4

Ku70 S155A/D156A mutant cells display altered
transcriptional regulation in response to DNA damage

DNA damage-induced apoptosis is largely regulated at the transcriptional level (48,
49), so we thought to investigate whether Ku S155A/D156A could interfere with the
transcriptional regulation of genes involved in the IR-induced apoptotic response. In
order to examine global gene expression differences between S155A/D156A and wildtype Ku70 expressing MEFs following IR, Affymetrix GeneChip analysis was performed
using RNA prepared from unirradiated control cells and from cells at 8 hours and 24
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Figure 2-4 Ku70 S155A/D156A expressing cells exhibit DNA damage signaling
defects.
(A) Analysis of IR-induced apoptosis in Ku70 S155A/D156A expressing cells. Irradiated
or mock-treated Ku70-/- MEFs expressing Ku70 wild-type (WT) or Ku70 S155A/D156A
were assayed for caspase-3 activity at the times indicated. Fold activation of caspase-3
activity is shown relative to the unirradiated control, averaged over 4 experiments with
error bars representing the SEM (**P <0.01, * P <0.05). (B) S155A/D156A Ku70
mutant cells display prolonged H2AX serine 139 phosphorylation (γ-H2AX) 24 hours
post-IR. Cells as in A were irradiated with 4 Gy of IR or mock treated, fixed at the time
points indicated, and subjected to analysis with a γ-H2AX antibody and DAPI. Foci were
quantified based on pixel intensity and averaged over the number of cells present (a.u.,
arbitrary units). Data represents the average of 4 separate experiments, each assessing
approximately 500 cells, and error bars represent SEM (*P <0.05).
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hours post-IR treatment. We noticed that the change of expression of several genes
induced or repressed by IR was reduced in Ku S155A/D156A expressing cells
(Supplementary Table 2-1). Genes found differentially regulated in WT and S155A/
D156A cells included the Inhibitor of differentiation (Id) genes (Id1, Id2, Id3), Activating
Transcription Factor 3 (ATF3) and Growth arrest and DNA damage-inducible gene 153
(GADD153), also known as DNA-damage-inducible transcript 3 (Ddit3) and C/EBPhomologous protein (CHOP), which have previously been characterized as participating
in the regulation of apoptosis (50-53). Id1 was shown to be downregulated by ATF3
during stress (53, 54), whereas GADD153/CHOP was found to be upregulated by ATF3
to induce cell death programs in response to stress (55, 56). Change of expression of
these genes was confirmed using quantitative RT-PCR analysis. Downregulation of Id1
and Id2 expression in response to IR was found severely inhibited in Ku70 S155A/
D156A cells while Id3 also showed a decreased inhibition, albeit less pronounced (Figure
2-5A). The induction of GADD153/CHOP was also affected 24 hours post-IR in cells
expressing Ku70 S155A/D156A (Figure 2-5B). Western blot analysis further confirmed
the reduction in GADD153/CHOP protein expression in Ku70 S155A/D156A mutant
cells compared to wild-type (Figure 2-5C). Since ATF3 activation would be expected to
precede that of its target genes Id1 and GADD153/CHOP, we tested ATF3 protein levels
in Ku70 wild-type and S155A/D156A mutant cells by western blot at earlier time points
following IR treatment. A marked decrease in ATF3 induction in cells expressing Ku70
S155A/D156A was detected 2 and 8 hours after IR treatment and was still noticeable at
16 hours post-IR, confirming that Ku70 S155A/D156A interferes with and/or delays
ATF3 activation (Figure 2-5D). Altogether, these results
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Figure 2-5 S155A/D156A Ku70 expressing cells show altered expression of ATF3,
GADD153/CHOP and Id1, Id2, and Id3 in response to IR.
(A) RT-PCR analysis of Id family genes Id1, Id2, and Id3. RNA samples from Ku70
S155A/D156A (Mt) and Ku70 wild-type (WT) expressing MEFs, 24 hours following 6
Gy of irradiation or unirradiated control cells were analyzed by RT-qPCR with primers
for the indicated Id genes (Id1, Id2, Id3). Fold change of gene expression relative to that
of unirradiated control samples is shown with error bars indicating SEM. For all samples,
P <0.05 between WT and Mt. (B) RT-PCR analysis of pro-apoptotic GADD153/CHOP
expression. RNA samples were processed as in A and RT-qPCR was performed using
primers specific for GADD153/CHOP (P <0.05).

(C)

Western blot analysis of

GADD153/CHOP protein levels in Ku70 S155A/D156A (Mt) and Ku70 wild-type (WT)
MEFs following IR. Representative western blot analysis of cells irradiated at 6 Gy or
mock treated (control) and extracts taken at the time points indicated. The membrane was
hybridized with the indicated antibodies. (D) Western blot analysis of ATF3 expression.
Cells were treated and harvested as in C at the times indicated and the blot was
hybridized with ATF3 and actin antibodies. Both panels are from the same blot, but a
longer exposure is shown for ATF3 in the left panel (no IR, 2h) due to weaker ATF3
signal intensity.
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suggest that the Ku70 S155A/D156A mutation impairs a signaling pathway that affects
ATF3 and its target genes in response to IR. ATF3 itself is regulated by ATF2, a
transcription factor of the same family (57, 58). Interestingly, we identified additional
genes known to be regulated by ATF2 and whose expression is altered by stress or DNA
damage that were differentially expressed in Ku wild-type and S155A/D156A cells in
response to IR (Supplementary Table 2-2). This suggested that the Ku70 S155/D156
residues could function to modulate the activation of an ATF2-dependent pathway in
response to IR.

2.3.5

Ku70 S155A/D156A inhibits ATF2 phosphorylation and foci
formation

ATF2 expression is not altered in response to IR, but ATF2 is rapidly recruited to IRinduced foci that co-localize with γ-H2AX (59). Foci formation by ATF2 is dependent on
phosphorylation of C-terminal residues (490, 498) (59). In addition, the activation of
ATF2 transcriptional activity in response to DNA damage and other forms of stress is
dependent on the phosphorylation of two residues in the N-terminal region (Thr69/71)
(57). Thus, to determine whether the Ku70 S155A/D156A mutation interfered with ATF2
activation in response to IR, we first analyzed ATF2 foci formation in Ku70-/- pMSCV
MEFs and cells re-expressing Ku70 wild-type and the Ku70 S155A/D156A mutant.
While all 3 cell lines displayed equivalent background level of ATF2 foci in untreated
cells, IR-induced ATF2 foci formation was much stronger in Ku deficient cells than in
cells re-expressing Ku70 wild-type (Figure 2-6A). Foci formation was reduced in cells
expressing Ku70 S155A/D156A compared to wild-type at both 1 and 4 hours after IR
treatment. Next, to determine whether Ku also modulated ATF2 phosphorylation at the
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Figure 2-6 Deficient ATF2 activation in response to DNA damage in Ku70
S155/D156 expressing cells.
(A) Representative images of ATF2 foci formation in response to IR in Ku70-/- MEFs
expressing wild-type Ku70 (WT), Ku70 S155A/D156A and empty vector (pMSCV).
Cells fixed either untreated (no IR) or 1h after IR (6 Gy) were stained with an ATF2
antibody and DAPI. Below, quantification of foci formation was done for unirradiated
cells (control) or cells processed 1h or 4h after IR treatment as described in Materials and
Methods

and

the

results

were

averaged

from

4

experiments

cells/experiments), with error bars representing SEM (*P<0.05).

(B)

(about

250

Cells were

analyzed as in A with a phospho-ATF2 (69/71) antibody. Representative images are
shown at the top, with quantification of phospho-ATF2 staining intensity from 3 separate
experiments shown below (a.u., arbitrary units of signal intensity). (C) Western blot
analysis of phospho-ATF2 (69/71) in Ku70-/- MEFs expressing wild-type Ku70 (WT) and
Ku70 S155A/D156A (Mt). Cells were left untreated (no IR) or subjected to 10 Gy and
collected at the time points indicated to prepare nuclear extracts. Western blot analysis
was done with a phospho-ATF2 69/71 antibody (p69/71) or with an ATF2 antibody to
determine total ATF2 protein expression and actin as indicated.
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N-terminal sites (Thr69/71) that activate ATF2 transcriptional function, we analyzed
phospho-ATF2 at the 69/71 residues using immunocytochemistry. IR-induced phospho69/71 ATF2 staining appeared mostly diffuse, but exhibited small foci (Figure 2-6B).
Similar to ATF2 foci formation, phospho 69/71 was enhanced in Ku-/- cells compared to
Ku70 wild-type MEFs, and reduced in Ku70 S155A/D156A at both time points tested.
To confirm the difference in phosphorylation at the ATF2 69/71 site between Ku70 wildtype and S155A/D156A mutant MEFs, we analyzed phospho-ATF2 by western blotting.
Consistent with the immunofluorescence result, a noticeable reduction in ATF2
phosphorylation was observed at all times points between 1 and 4 hours post-IR in Ku70
S155A/D156A MEFs compared to wild-type, suggesting that substitutions at S155/D156
impaired ATF2 69/71 phosphorylation (Figure 2-6C). Together, these results suggest that
Ku functions to repress ATF2 activation in response to DNA damage and that the
S155A/D156A mutation further enhances this repression.

2.3.6

Increased survival in response to IR is dependent on the
mutation of S155

The Ku70 S155/D156 residues are present in a loop region between α-helix 4 and αhelix 5 of the Ku70 vWA domain (32). The effect of the mutation could be due either to
the disruption of a key phosphorylation event on Ser155, or could simply be disrupting a
protein-protein interaction surface. To address the latter possibility, we produced a Ku70
mutant containing alanine substitutions across the entire loop (aa 155 to 160), reasoning
that extending the mutated surface could amplify the effect observed with the
S155A/D156A mutation. Analysis of IR survival curves revealed no significant
difference in survival between MEFs expressing the Ku70 155-160A mutant and those
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expressing the S155A/D156A mutant, suggesting that S155A/D156A alone conferred
maximal increased resistance to IR (Figure 2-7A). We next tested the effect of the single
S155A and D156A substitutions on cell survival in response to IR. Ku70 D156A
expression resulted in a survival profile not significantly different than wild-type Ku70.
The Ku70 S155A however, conferred enhanced survival that was similar to that of the
155-160 mutant and the double S155/6 mutation (Figure 2-7B). This suggests that the
DNA damage signaling events that modulate cell survival in response to IR are solely
dependent on Ku70 S155.
As this residues is a serine, it suggested the possibility that S155 might be targeted for
phosphorylation to modulate DNA damage signaling, and that the S to A substitution
prevented this crucial modification. To test this possibility, we generated an aspartic acid
mutant, S155D, to assess the effect of a phosphomimetic substitution on cell survival in
response to IR. Cells expressing Ku70 S155D appeared fragile and susceptible to cell
death. Also, while we confirmed expression of Ku70 S155D (Figure 2-7D), the protein
levels appeared to decline quickly in the first few passages following drug selection, and
only about 65% of MEFs were found expressing this mutant, versus over 90% for Ku70
WT and other mutants (Supplementary Table 2-2). Clonogenic assays revealed that the
Ku70 S155D mutation conferred a pronounced hypersensitivity to IR, as cells expressing
Ku70 S155D displayed even greater radiosensitivity than the Ku-deficient cells (Figure
2-7C). To determine the effect of the S155D substitution on ATF2 phosphorylation, we
compared ATF2 69/71 phosphorylation in cells expressing Ku70 S155D, Ku70 S155A,
wild-type Ku70 and Ku70-/- pMSCV MEFs. In control unirradiated cells, both Ku70deficient MEFs and S155D showed strong background levels of phospho-ATF2 in
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Figure 2-7 Ku70 S155A substitution is required and sufficient to confer increased
survival following IR.
(A)

Clonogenic assay of Ku70-/- MEFs expressing Ku70 with 155-160 alanine

substitutions (155-160A) and S155A/D156A in comparison Ku70-/- expressing wild-type
Ku70 (WT). Survival is expressed as the number of colonies present at each IR dose
relative to the unirradiated control, averaged over 3 experiments and with error bars
representing the SD (**P<0.01, *P<0.05). (B) Clonogenic assay comparing survival of
MEFs expressing Ku70 wild-type (WT) and Ku70 D156A and S155A substitutions.
Survival is expressed as in A. (*P<0.01). (C) Clonogenic assay of MEFs expressing
Ku70 wild-type (WT), Ku70 S155A and empty pMSCV vector (KO) in comparison to
Ku70 bearing the phosphomimetic S155D substitution. Survival is expressed as in A.
WT, S155A and pMSCV are significantly different from each other at all time points
(P<0.05), but the stars indicating significance are omitted for clarity. Significance is
indicated for S155D compared to pMSCV (*P<0.001). (D) Western blot analysis of Ku
subunits expression in Ku70-/- MEFs expressing empty vector (pMSCV), wild-type Ku70
(WT), or Ku70 mutants as indicated. (E) Western blot analysis of phospho-ATF2
(69/71) in Ku70-/- MEFs expressing wild-type Ku70 (WT), Ku70 S155A and Ku70
S155D or empty vector (pMSCV). Cells were either left untreated (no IR) or subjected to
10 Gy and collected 2 hours later. Western blot analysis was done with a phospho-ATF2
69/71 antibody (p69/71), an ATF2 antibody to determine total ATF2 protein expression
and actin as indicated.
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comparison to Ku70 wild-type and S155A (Figure 2-7E). In response to IR, as expected,
phospho-ATF2 was enhanced in Ku-deficient cells and reduced in Ku70 S155A
compared to Ku70 wild-type. As well, Ku70 S155D expressing cells displayed increased
levels of phospho-ATF2 in comparison to Ku70 wild-type. Thus, these results are
consistent with a phosphomimetic effect of the Asp substitution and support the notion
that Ku70 S155 phosphorylation in response to IR is an important event that activates
apoptotic pathways in response to DNA damage.

2.4

Discussion

This study identifies a novel function for Ku in regulating signaling pathways leading
to apoptosis in response to DNA damage. This regulation occurs through a previously
uncharacterized region near α-helix 4 in the Ku70 vWA domain. Amino acid
substitutions in this region, while not affecting DNA repair, compromise the activation of
apoptosis, and alter the transcriptional profile of genes regulated by an ATF2/ATF3
pathway.
Previous studies have shown the involvement of the Ku70 vWA domain in C-NHEJ.
A recent study demonstrated that Ku has a 5’ lyase activity that is conferred by specific
residues in the Ku70 vWA, supporting a direct role for Ku in end-processing (27). This
activity was found to be dependent on an N-terminal “active site” (aa 4-34) and on three
lysine residues within the Ku70 N-terminal domain. In yeast, Ku70 α-helix 5 was found
to convey crucial C-NHEJ functions (38). We show here that substitutions in the
corresponding human Ku70 α-helix 5 residues (D192A/D195R) caused a survival defect
in MEFs, consistent with an C-NHEJ defect. α-helix 5 is an exposed α-helix facing
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towards the DNA terminus that is well conserved from yeast to man (Figure 1)(38).
While the underlying cause of this DNA repair defect is still unknown, this implies that
the function of this Ku region is evolutionarily conserved. Mutations in α-helices 3 and 4
did not cause any obvious defects. Our results are consistent with previous findings in
yeast showing that α-helix 4 mutations do not affect C-NHEJ (38). Additionally, it
should be pointed out that α-helix 3 is positioned away from the DNA and therefore may
be less likely to function in DNA repair process (32, 38).
In contrast to the aforementioned involvement of vWA regions in C-NHEJ, the Ku70
S155A/D156A mutation is fully functional for DNA repair, suggesting that these residues
are not involved in the interaction of Ku with C-NHEJ factors. In particular, it also
indicates that these substitutions do not interfere with the overall DNA-PK kinase activity
which is known to be required for C-NHEJ and defects in which result in IR sensitivity
(13, 60). Since the DNA-PKcs region of interaction with Ku lies in the Ku80 C-terminal
domain, it is unlikely to be affected by a Ku70 N-terminal substitution. However, the
possibility remains that S155A/D156A could interfere with phosphorylation of specific
targets by DNA-PK.
The increased survival of the MEFs expressing Ku70 S155A/D156A correlated with
a marked decrease in apoptosis as measured by caspase-3 activation. In contrast to wildtype cells, persistent γ-H2AX foci were present 24h following IR, suggestive of the
presence of residual unrepaired DNA breaks. Since Ku70 S155A/D156A does not confer
any repair defects, the persistence of γ-H2AX foci suggests defects in DNA damage
signaling. γ-H2AX foci present at 24 hours may indicate DSBs that were unable to be
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repaired and would normally trigger apoptotic pathway activation to eliminate the
damaged cells. We postulate that in Ku wild-type cells, the activation of apoptotic
pathways allows the return of γ-H2AX foci to background levels, whereas defects in
signaling to apoptosis in Ku70 S155A/D156A delays or impedes foci disappearance in
these cells.
Since Ku70 S155A/D156A resulted in apoptotic defects, we first investigated
whether it could affect p53, since this factor is a major regulator of apoptotic pathways in
response to DNA damage (49). Analysis of p53 response to IR revealed that p53
expression is not induced in either Ku wild-type or Ku70 S155A/D156A cells
(Supplementary Figure 2-3), suggesting that the immortalization of the Ku Ku70-/- MEFs
disrupted p53 regulation, an event that frequently occurs in the process of MEFs
immortalization (61). However, p53 was efficiently phosphorylated at Ser 15 (Ser 18 in
mouse) in response to IR, suggesting that the ATM-dependent signaling which is
responsible for p53 phosphorylation at this site is intact in these cells (62). Importantly,
no difference in the efficiency of phosphorylation was observed between wild-type and
Ku70 S155A/D156A cells, suggesting that the effect of Ku on signaling to apoptosis does
not affect p53 response nor appears to be p53 dependent (Supplementary Figure 2-3).
The altered expression of several genes involved in an ATF2/ATF3 signaling
pathway in Ku70 S155A/D156A cells led us to speculate that Ku functions to regulate
this signaling pathway in response to IR. ATF3 is a basic-region leucine zipper (bZIP)
transcription factor member of the ATF/CREB superfamily that is rapidly upregulated by
a variety of stress signals including DNA damage (51, 58, 63, 64). ATF3 can function
both to activate and repress transcription, depending on its dimerization partner and the
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promoter context. Several studies have demonstrated a crucial role for ATF3 activity in
inducing apoptosis and the suppression of tumorigenesis (51, 65, 66). Furthermore, ATF3
is directly involved in down-regulating Id1 expression, while contributing to
GADD153/CHOP transcriptional activation (53, 55). While Id1 has been shown to be
directly regulated by ATF3, Id2 and Id3 expression is not well characterized but there is
evidence that they are regulated coordinately (52, 67). Id proteins function as dominantnegative antagonists of the basic helix-loop-helix (bHLH) family of transcription factors
and play roles in development, tumorigenesis and cell cycle by promoting cell survival
and proliferation (52, 67). Overexpression of Id proteins correlates with tumorigenesis
and downregulation of Id1 expression sensitizes cells to apoptotic agents (52, 67-69).
Finally, previous studies have shown that Id1 is downregulated in response to stress and
DNA damage in an ATF3-dependent manner (53, 54). Consistent with these studies, our
RT-PCR analyses showed a strong downregulation of Id1 following IR treatment,
concurrent with that of Id2 and Id3. In Ku70 S155A/D156A cells, this repression was
substantially lessened, correlating with reduced activation of ATF3. Thus, the combined
IR-induced regulation of these transcription factors converge towards the regulation of
apoptosis and their dysregulation in Ku70 S155A/D156A cells is consistent with the
reduced activation of apoptosis observed in response to DNA damage.
ATF3 activation is mediated by several factors and pathways depending on the
activating stimulus (51, 56). DNA damage activation of ATF3 has been suggested to
depend on an ATM-NBS1 pathway, and ATF2 (58). Recent studies have implicated
ATF2 in the DDR (59, 70). In response to DNA damage, ATF2 transcriptional activity is
activated by phosphorylation at N-terminal residues T69/71 by p38 and Jun-N-terminal
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Kinase (JNK) in an ATM-dependent manner (58, 71, 72). In addition, ATF2 is
phosphorylated at C-terminal S490/498 by ATM, resulting in its accumulation at IRinduced foci that co-localize with γ-H2AX and the MRN complex (59). Mutation of these
residues results in loss of ATF2 foci formation, defective DNA damage response and
confer increased sensitivity to IR and tumour susceptibility in mice (59, 70).
Analysis of ATF2 IR-induced foci formation and T69/71 phosphorylation showed
that both were affected by Ku expression and Ku70 S155A/D156A mutation. Previously,
it was determined that while mutation of ATF2 S490/498 prevented foci formation,
T69/71 phosphorylation was dispensable for ATF2 localization into foci, and
phosphorylation at both sites were suggested to be independent events (59, 71). The
relationship between these two phosphorylation events is still unclear as ATM is required
for ATF2 T69/71 phosphorylation (58), but whether T69/71 phosphorylation is an
independent event, or is contingent on S490/498 modification has not been determined.
We found that phospho T69/71-ATF2 is localized into IR-induced foci. This infers the
existence of an ATF2 population that is phosphorylated at both N-terminal and Cterminal motifs suggesting that phosphorylation at both sites is not exclusive and that
transcriptionally active ATF2 is present at DNA breaks. Thus, our results suggest that Ku
functions to modulate both events whether or not they are independent of one another.
The deregulation of several genes directly or indirectly dependent on ATF2
transcriptional activity in Ku70 S155A/D156A cells suggests that this mutation can
interfere with the transcriptional activity of ATF2 mediated by T69/71 phosphorylation.
Phosphorylation of T69/71 is induced in Ku70-/- cells compared to wild-type, suggesting
that Ku plays an inhibitory role on ATF2 transcriptional activation in response to IR.
100

101

Since ATF2 T69/71 phosphorylation initiates signaling cascades leading to the activation
of apoptosis, one potential explanation is that Ku-mediated inhibition of ATF2 activation
is linked to Ku’s ability to activate DNA repair. Ku-mediated assembly of a functional CNHEJ complex and/or completion of DNA repair could prevent ATF2 activation. In the
case of overwhelming DSBs, Ku may be present at the break, however, may not be able
to assemble a functional repair complex because of the limiting availability of other CNHEJ factors, thus allowing ATF2 phosphorylation and the establishment of a signaling
pathway leading to the activation of apoptosis. The increased repression of ATF2
phosphorylation by Ku70 S155A suggests that this mutation disrupts an event that
normally allows ATF2 activation when DNA repair is not completed. As ATF2
phosphorylation and activation in response to DNA damage is ATM dependent (58, 59),
the Ku70 vWA region may function to link Ku to ATM signaling and modulate an ATMdependent pathway.
We demonstrated that S155 is the essential residue implicated in this regulation of
cell survival. As serine/threonine kinases are an integral part of the DNA damage
response signaling pathway, the S155A mutation could be preventing an important posttranslational signaling event in the regulation of apoptosis. However, S155 has not been
previously identified as a DNA-PK phosphorylation site on Ku70 (73), nor is it located in
any canonical kinase phosphorylation motif (as determined using NetworKIN) (74).
Interestingly, a recent proteomics study analyzing site-specific phosphorylation after IR
treatment identified a new DNA damage-related phosphorylation motif, SXXQ, which
was overrepresented amongst phospho-sites regulated within 1 hour following IR
treatment (75). Peptides with this motif were found to follow a profile of phosphorylation
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similar to that of SQ motifs, suggesting that this site could be targeted by ATM or DNAPK. S155 is located in a SXXQ motif (SDVQ – Figure 2-1), thus making these two
kinases prime candidates for a phosphorylation event at this site. Future experiments will
have to determine whether ATM or DNA-PK can phosphorylate this site and whether
phosphorylation of S155 is indeed responsible for the modulation of cell survival through
regulation of ATF2-dependent pathway.
The idea that S155 is a phosphorylation site is supported by our experimental results
showing that that the survival advantage conferred by the S155A substitution is
completely overturned by the S155D mutation. This suggests that this phosphomimetic
substitution provides for a constitutive activation of apoptosis irrespective of DNA repair.
Somewhat surprisingly, cells expressing Ku70 S155D displayed an even more
pronounced hypersensitivity to IR than cells lacking Ku. ATF2 phosphorylation appeared
similar in Ku-deficient and S155D within the limit of sensitivity of the western blot
analysis. Thus, it is possible that Ku70 phosphorylation at S155 not only potentiates
ATF2 phosphorylation but also has additional effects that contribute to further activation
of downstream apoptotic pathways.
The apoptotic pathway regulated by Ku identified in this study seems independent
from the control of Bax by Ku70 described in previous studies (76). First, the Bax-Ku70
interaction that has been described relies on the acetylation of several residues in the
Ku70 C-terminal domain, thus in a region that is quite distinct from S155 in the Nterminal domain (77). Second, Bax regulation by Ku70 hinges on the modulation of an
interaction between Bax and Ku that has been suggested to occur in the cytoplasm (40),
while the regulation that we have uncovered here involves the interplay between proteins
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that form DNA-induced foci at DNA breaks. However, further investigations will be
needed to determine whether Ku70 S155 modulates the activation of apoptosis through
other pathways and in particular, whether Ku-Bax interaction is affected by this
regulation.
Finally, it is interesting to consider the positioning of the α-helix 5 residues (D192,
D195) which mutation confers a DNA repair defect in yeast and that we have confirmed
here severely impair viability, and the loop region adjacent to α-helix 4 where the S155 is
located. Both are facing outwards, towards the DNA break (Figure 2-1B), in proximity to
one another, suggesting the potential for interactions or cross-talk between the two
regions. Because of its presence at the DNA break and its primary function in C-NHEJ,
Ku is well positioned to act as a “sensor” of DNA repair. Therefore, the proximity of αhelix 5, which appears essential for DNA repair, to the S155 residues suggests that Ku
could function to relay signals from the repair machinery to nearby regulators of
signaling pathways that control apoptosis.
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Supplementary materials

Supplementary Figure 2-1 Retroviral mediated re-expression of Ku70 in Ku70
deficient MEFs restores WT protein level
Western blot analysis of Ku70 protein level in normal WT MEFs, Ku70 -/- MEFs or
Ku70 -/- MEFs that have stable integration of human Ku70 cDNA mediated through the
pMSCV retroviral system.
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Supplementary Figure 2-2 Ku70 vWA mutations that do not alter survival after IR
(A) Several vWa alanine mutations have no effect on Ku70’s function in response to IR.
MEFs expressing Ku70 wild-type or Ku70 with the Ku70 mutants bearing substitutions at
the amino acids indicated were irradiated and processed by clonogenic assay. Survival is
expressed as the number of colonies present at each IR dose relative to the unirradiated
control, averaged over 3 experiments and with error bars representing the SD. (B)
Western blot analysis of Ku70 and Ku80 expression in Ku70-/- MEFs re-expressing
Ku70 with the indicated substitutions.
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Supplementary Table 2-1 List of genes differentially regulated after IR in
S155A/D156A Ku70 expressing MEFs relative to WT Ku70.

Samples from control and IR-treated (8h and 24h) MEFs were subjected to microarray
analysis using a GeneChip Mouse Gene 1.0 ST Array (Affymetrics, Santa Clara, CA).
Gene Chips were processed at the London Regional Genomics Centre (Robarts Research
Institute, London, ON; http://www.lrgc.ca). Fold induction/repression of expression with
respect to unirradiated controls was calculated for each gene and cell line. The fold
difference in gene expression change between Ku70 wild-type relative to S155A/D156A
expressing MEFs is shown for those genes with a 1.4 fold or greater difference at either
the 8h or 24h time point. The data shown for the 8h time point is an average of two
replicates, while the data shown for the 24h time point is the result of a single
experiment.
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Mamdc2
Ppef1
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  WT:MUT
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3.9187995
3.8577384
3.8113957
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2.104408 1.46146333
2.0961174
2.0844516 1.53372609
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2.0410395 1.54167379
2.0379489 1.43704731
2.0354801
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2.0067536
1.4895575
1.9957273 1.45625149
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1.9248572 1.41269609

113
Hsph1
Slc38a7
Tlr4
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1.9082634
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1.8975173
1.8939079
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1.8856593
1.8766199
1.8723637
1.8673431
1.8656155
1.8597088
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1.8575405
1.8563811
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1.8503534
1.84989
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1.8267631
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1.8247174
1.8243079
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1.8219247
1.8217202
1.8204641
1.8201073
1.8159801
1.8091591
1.8089528
1.8053534
1.8049026
1.8001194
1.7937267
1.7909338
1.7905111
1.7881917
1.778258
1.7745176
1.7739278
1.7718354
1.7701335
1.7696444
1.7689527
1.7682591
1.7678159
1.762365
1.7564347
1.7560198
1.753066
1.7525657

1.65098897
1.4318617
1.45468866

1.48136664
-‐1.8983005
1.65473887

1.42197637
1.51269976
1.46698769

1.41164796
1.44535087

1.4153378
1.54459317
1.48618771
1.40688498
1.77865379
1.48560589

1.46929767
1.40473952
1.74855875
1.52447539
1.48256428
1.48911203
1.46282945
1.45749417
1.5736287
1.63043417
1.51032446

Cyp4f40
Gramd1b
Hexb
Cyb5
Prrx2
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Gjb2
Fzd4
Chchd10
Ampd3
Mknk1
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Mfsd11
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Fgd6
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Syk
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Lonp1
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Chpf2
Id1
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Tpp1
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Ifrg15
Hspa8
Hspa8
Gabre
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Ucp2
Chic1
Chmp2b
Herpud2
Id3
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Mapkapk3
Atad5
Cxx1c
Zc3h6
Zmym6
Hbp1
Srrt
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Usp53
Lmbrd1
Pip4k2c
Mcoln1
Stx3
Gga2
Tmem140
Prnp
Npy1r

1.7517139
1.7501591
1.7454734
1.7450522
1.7423045
1.7412096
1.7401819
1.7321927
1.727917
1.7253922
1.7250074
1.7227924
1.7219822
1.7181514
1.7170835
1.7160801
1.7154287
1.7118254
1.7116953
1.7103442
1.7073638
1.7070799
1.7012834
1.6973613
1.6949752
1.6866234
1.6864841
1.6857916
1.6839586
1.6830456
1.6806551
1.6763219
1.6663143
1.659868
1.6581147
1.6553069
1.6534133
1.653137
1.6523057
1.6511606
1.6466074
1.6461378
1.6448174
1.6401412
1.6348365
1.6345893
1.6327409
1.6303987
1.6298901
1.6286135
1.6279505
1.6273531
1.6230606
1.6196043
1.6180539
1.6180375
1.6175543
1.6164847

1.90172375

Pqlc3
Slc17a5
Rnf185
1.70241229
Iah1
1.68804388 Ccdc28a
Spag7
1.48240281 Map3k2
1.68345095 D14Ertd436e
1.47141192
Sox2
Fnip2
Gnb4
LOC100043377
1.42178657
Sel1l
Intu
Agap1
Hdac4
Neu1
Sars2
1.47156095
Rad9
Pvr
1.40014645
Pawr
Snhg1
1.48595993
Nipa1
Trappc1
Eprs
Letm2
Slc38a1
1.4067943
Eif4g3
Zfp655
Prkar2b
1.45188925 Slc26a11
1.44682077
Eea1
1.60901173
Ccdc15
1.4231927
Tollip
Slc35b4
-‐1.4602673
Gnpda1
Tbcel
Snx32
Ahcyl2
1.46457371
Trib1
1.59264985
Ier5l
1.46947343
Kdsr
Nbr1
1.43671172
Tnrc6c
1.49781831
Armcx1
1.42376192
Slc23a3
Pon2
Adh7
-‐1.415566
Mfap1a
Atad2b
Fam178a
Trpm7
Diap2
1.59749504
Gem
1.40142053
Clcn7
Rab39b
Phf3
Rab11fip1

1.612958
1.6125943
1.6101383
1.6101325
1.6082784
1.6075526
1.6048082
1.6029689
1.600814
1.6007837
1.5982597
1.5974348
1.5945581
1.5922669
1.590925
1.5874177
1.5849638
1.5816334
1.580551
1.5801369
1.5773272
1.5773082
1.5759317
1.5755968
1.57551
1.5754116
1.5750848
1.574932
1.5734067
1.5696642
1.5672707
1.5632144
1.5594109
1.5592433
1.5585174
1.5567131
1.555061
1.552689
1.5525451
1.5384128
1.5316894
1.5315071
1.5310058
1.5282717
1.5270307
1.5265664
1.5231683
1.5224364
1.5217243
1.5206588
1.5192538
1.5180277
1.5152733
1.5141896
1.5132979
1.5109985
1.5099878
1.5097985

1.42473953

1.53144538
1.4139656

1.43661194

1.49667647

1.63090913
1.45918755
1.63132614
1.56915774

1.4052844
1.45887399
1.52206363
1.48788782

1.50676698

1.48729289

1.43555531

1.42091663

1.48356497
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Rnaset2a
Pex1
Gpr174
Gtf2a1
Atp6v1b2
Kctd11
Adamtsl4
Zc3h6
Itpr2
Arl5b
Phf20l1
Ccl9
Cebpg
Tmem194
Wdr7
Mfap1a
Zbtb24
Rnf214
Extl1
Strbp
Ankle1
Mafg
Vcpip1
Samd8
Adamts9
Slc3a1
Rnf145
Cdt1
Nfx1
Psmd3
Epc2
Cdh11
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Cmklr1
Gclm
Zfyve27
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Slc25a36
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Wdr76
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Hsdl1
Tmem206
Adh1
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1.4455486
1.4453161
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1.4425209
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1.4363899
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1.4184922
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1.54601296

1.45204123
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1.5963841

1.4554497
1.40290202
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1.5735995
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1.40378536
1.47489082
1.40230701
1.40823223

1.73231704

1.48761848

Cfp
Hspa1a
Tom1
Prkg2
Chaf1b
Stambpl1
Pfkfb2
Zfyve1
Wwtr1
Zfyve26
Gtlf3b
Zbtb34
Fuca2
Fdft1
Nsl1
Bag4
Cd59a
Sh3bgrl2
Zxdc
Fam33a
Fam171a2
Fam175b
Ahi1
Mxd3
Klhdc1
Taf4b
Dbt
H2-‐Q6
Lpar1
Zfp30
Thap6
Cd274
Necab3
Osbpl8
Sema3a
Snrpd2
Aldh3b1
Dhtkd1
Dmxl2
Samd9l
Plec1
Dap
Sirt1
Wnt10b
Zc3h8
Neto2
Lin54
Atp6v1a
Psca
Wnt10a
Impact
Aoc2
Atg12
Rnf146
Zfp346
Tpm1
Tcn2
Hsd17b1

1.4139547
1.4134225
1.4121067
1.4080633
1.4064953
1.4064801
1.4049028
1.4039952
1.4005728
1.4001212
-‐1.407985
-‐1.408413
-‐1.410325
-‐1.41511
-‐1.423584
-‐1.432748
-‐1.434654
-‐1.44526
-‐1.45311
-‐1.462599
-‐1.467632
-‐1.468052
-‐1.471704
-‐1.47245
-‐1.480162
-‐1.481357
-‐1.489391
-‐1.490049
-‐1.49507
-‐1.497653
-‐1.499752
-‐1.500081
-‐1.503617
-‐1.507525
-‐1.510492
-‐1.511373
-‐1.515173
-‐1.517589
-‐1.519363
-‐1.521593
-‐1.532722
-‐1.534666
-‐1.542143
-‐1.547559
-‐1.548371
-‐1.555185
-‐1.567111
-‐1.570635
-‐1.570887
-‐1.575599
-‐1.578538
-‐1.5795
-‐1.581043
-‐1.582225
-‐1.585801
-‐1.58908
-‐1.589205
-‐1.601239

1.48405674

1.66129296
1.71930121
1.56897416
1.53878605
1.47207129
1.40060564

1.62662905
1.47968148
1.49090007
1.47642871
1.56514538
1.44982344
1.42272694
1.63709957
1.50306935
-‐1.4169811

1.43467441

-‐1.477496
-‐1.4413662

1.40814151
1.54009213

-‐1.5677594
1.45227314

Tom1l2
Elovl3
Atp6v1h
Mgst3
Marcks
Col1a1
Gnpda2
Idua
Dab2
Ypel2
Phospho2
Vaultrc5
Slc25a44
F3
Helq
Nhlrc3
Cd248
St3gal5
Lcn2
Cp
Galc
Tmem68
Acss2
Rragb
Napb
Soat1
Lss
Tceal1
Elovl4
Pla2g12a
Slc25a1
Cpeb4
Nfxl1
Zscan4c
Pcyt2
Abcc4
Sqle
Pde5a
Vcl
Slc38a4
Mvk
Zbtb10
Acat2
Nxn
Pgr15l
Fads2
Prkca
Utp14a
Tubb6
Pgd
Nqo1
Col1a2
Mvd
Aspn
Csprs
Mtap1a
Gnpnat1
Fam135a

-‐1.6045891
-‐1.6252544
-‐1.6356868
-‐1.6517545
-‐1.6628105
-‐1.6640281
-‐1.6650639
-‐1.6676651
-‐1.6834219
-‐1.6915289
-‐1.699858
-‐1.7089014
-‐1.7254237
-‐1.7347191
-‐1.7572803
-‐1.7578207
-‐1.7607058
-‐1.7623064
-‐1.765672
-‐1.7675866
-‐1.7676586
-‐1.7800826
-‐1.7874627
-‐1.7878325
-‐1.791784
-‐1.7977704
-‐1.8280634
-‐1.8488098
-‐1.8545102
-‐1.8695517
-‐1.8788746
-‐1.8811509
-‐1.8818451
-‐1.8838396
-‐1.8851732
-‐1.8871846
-‐1.9184307
-‐1.9254491
-‐1.9363655
-‐1.9444142
-‐1.9457642
-‐1.9583813
-‐1.973115
-‐1.9754234
-‐1.9896853
-‐1.989967
-‐2.0061759
-‐2.0133472
-‐2.0219033
-‐2.0287838
-‐2.0444974
-‐2.1126376
-‐2.1305326
-‐2.1322411
-‐2.1352281
-‐2.1716436
-‐2.1853354
-‐2.1886646

1.44938259
1.99057739
1.5266622
1.84515731
1.62336255
1.48600963
1.57361035
1.54727112

1.73818215
1.44880528
1.56087793
1.62414217
1.90026662
1.49131409
1.41532747
1.43521665
1.70021597
1.86651919
2.10983143
1.46001437
1.58677832
1.44630792
1.56032003
1.57718606

1.5336036
1.51993276
-‐1.67106105
1.47501292
-‐1.43402451
1.49623692
1.58697369
1.80621337
1.46131124
1.47388768
2.03752985
-‐1.60581872
-‐1.46089205
1.76271345
1.50664876
-‐1.66362682
1.93115753
4.32184981
-‐1.57415996
1.53632549
1.44703985
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Ehd2
Gnpnat1
Nsdhl
Cdkn2b
Figf
Cnn2
Hmgcs1
Elovl6
Kirrel3
Phyhd1
Mrgprf
Fabp5
Lonrf3
Fabp5
Arap2
Ldlr
Dhcr24
Mest
Ccl2
Gm10661

-‐2.198438
-‐2.2427114
-‐2.2681434
-‐2.3181381
-‐2.3378437
-‐2.406833
-‐2.4936242
-‐2.5645781
-‐2.7847759
-‐2.8151805
-‐2.8627782
-‐2.8785812
-‐2.9056867
-‐2.9136574
-‐2.930112
-‐2.9911491
-‐3.0019595
-‐3.5311891
-‐4.2690591

-‐1.4310684
1.59901817
1.85714563
1.72873896
-‐2.2676749
-‐1.6980701
2.01395713
2.13365248
2.00441949
1.86917757
-‐2.436233
2.34144448
2.56711674
2.31190941
2.36875016
1.75481201
-‐2.2866797
2.06437933
1.99061696

Thbd
Fam59b
V1rb4
Zfp772
Gas5
Gm5081
Pim3
Cftr
Zfp715
Acvr2a
Akap10
Tmem56
Dnajc28
Slc7a3
Plb1
Tmem144
Dusp4
Mknk1
Bbs4
Prr5l

1.57758372
1.5577031
1.55313017
1.54561075
1.53413439
1.53201016
1.53006309
1.50134217
1.4848643
1.47278634
1.47200656
1.87443102
1.79032135
1.761308
1.73891601
1.66376254
1.64606874
1.61237653
1.60533845
1.6002238

Mfsd7c
Sfmbt1
Errfi1
Taf1b
Armcx3
Ccl25
Zbtb26
Zfp52
Zfp113
Lrrc8d
H2-‐gs10
Marcksl1
C2cd2l
Creg1
Cldn12
Zfp84
Pmvk
Ranbp6
Kctd13

1.59639171
1.46812573
1.46644845
1.46061889
1.45633319
1.45094145
1.44200967
1.43849797
1.43517177
1.43182828
1.4310383
1.42322118
1.41497937
1.4138431
1.4045209
1.40376018
-‐1.40292587
-‐1.48558738
-‐1.59967382
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Supplementary Table 2-2 List of ATF2 dependent genes differentially regulated
after IR in S155A/D156A Ku70 expressing MEFs relative to WT Ku70.
Samples from control and IR-treated (8h and 24h) MEFs were subjected to microarray
analysis using a GeneChip Mouse Gene 1.0 ST Array (Affymetrics, Santa Clara, CA).
Gene Chips were processed at the London Regional Genomics Centre (Robarts Research
Institute, London, ON; http://www.lrgc.ca). Shown is the list of genes previously
identified as regulated by either ATF3 or ATF2 that were found differentially expressed
in Ku70 wild-type and Ku70 S155A/D156A cells following IR exposure. Fold
induction/repression of expression with respect to unirradiated controls is shown for each
gene and the difference in gene expression between Ku70 wild-type and S155A/D156A
mutants is shown in brackets.
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Supplementary Table 2-2 Ku70 vWA mutant expression
Immunofluorescence analysis of Ku70 expression in untreated Ku70-/- MEFs expressing
either the WT or mutant Ku70 constructs. Cells were marked positive if showing a Ku70
expression level above that seen in Ku70-/- + pMSCV cells (Ku70 positive) and were
also stained with DAPI for total cell count numbers (Total). Expression level is calculated
as a percent of Ku70 positive cells relative to the total cell count (%).
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Supplementary Figure 2-3 S155A/D156A Ku70 expression does not inhibit
phosphorylation of p53 at serine 15.
Western blot analysis of total p53 and p53 phosphorylated at residue serine 15 (pSer15)
in wild type (WT) or S155A/D156A (A) Ku70 expressing MEFs that were either mock
treated or exposed to 4 Gy of IR and collected after the indicated time points.
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Supplementary Table 2-4 Primers used in this study
(A) Primers used for site-directed mutagenesis of Ku70. (B) Primers used for RT-PCR
analyses.
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Chapter 3

3

Ku70 phosphorylation mediates Aurora B inhibition and
activation of the DNA damage response
3.1

Introduction

Double-strand breaks (DSBs) are the most dangerous form of DNA damage, as
improperly repaired, they can result in genetic alterations, leading to genomic instability,
a hallmark of cancer. Eukaryotic cells employ DNA damage checkpoint surveillance
mechanisms to allow the damaged cell time to repair its DNA, or eliminate cells damaged
beyond repair through apoptosis and senescence (1, 2).
The DNA damage response (DDR) pathway is initiated by sensor proteins that
accumulate in foci at the site of damage (1, 3). This accumulation of DDR proteins
activates a phosphorylation cascade as well as modifies surrounding chromatin to allow
access of the DNA repair factors. The initial sensors include the Mre11-Rad50-NBS1
(MRN) complex, 53BP1, as well as the serine/threonine (S/T) phosphoinositide-3-kinase
(PI3K) family members ATM (Ataxia Telangiectasia Mutated), and ATR (Ataxia
Telangiectasia and Rad3-related). The PI3K-like kinases are the main regulators of the
DDR and orchestrate many phosphorylation events at the site of DNA damage that
promote DNA repair (3). The consequences of DNA damage involve temporary cell
cycle arrest to allow for DNA repair and activation of senescence or apoptotic pathways
if repair cannot be completed (2, 4). Cellular senescence, although not cytotoxic, is the
irreversible exit from the cell cycle, while apoptosis is a form of programmed cell death.
Both prevent the proliferation of potentially genomically unstable cells, thereby
eliminating the chance of neoplastic transformation (2, 4).
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Aurora kinases (Aurora-A, -B and -C) are a family of serine/threonine kinases
that play essential roles in cell cycle progression (5). Aurora B coordinates the mitotic
process, functioning to regulate many aspects of mitosis including chromosomemicrotubule interactions, spindle assembly, sister chromatid and centromeric cohesion
and cytokinesis (5). Aurora B’s activities, however, are not restricted to mitosis, as it is
expressed throughout the cell cycle and there is evidence that it also contributes to G1/S
and G2/M checkpoint regulation (6, 7). As a mitotic kinase, Aurora B kinase activity is
tightly regulated during cell cycle checkpoints and deregulation of its activity can have
devastating consequences. Ectopic expression of both Aurora A and B results in
chromosomal abnormalities and cellular transformation, and overexpression of Aurora
kinases is observed in a number of different cancers (5, 8-10). Consequently Aurora
kinases were identified as possible druggable targets and a number of Aurora kinases
inhibitors have been developed for anti-cancer therapy (8, 11). Aurora B inhibitors were
shown to prevent cytokinesis and cause cell growth inhibition and cell cycle arrest (1214). While Aurora B has been implicated in the cellular response to DNA damaging
agents (15, 16), a thorough understanding of the regulation of Aurora kinase activity
following genotoxic stress is lacking.
DSBs are repaired by one of three pathways: homologous recombination (HR),
which occurs primarily in the G2 and M phases, micro-homology mediated end joining
(MMEJ), a backup pathway, and non-homologous end joining (NHEJ), the predominant
repair pathway in higher eukaryotes, which occurs in the G1 and S phases (17, 18). Ku
has a well-characterized role as the DNA binding component of NHEJ (19). Ku is a
heterodimer composed of subunits Ku70 and Ku80 (70 and 86 kDa, respectively) which
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share structural similarity and are conserved from bacteria to man. Each subunit contains
an N terminal α/ß von Willebrand A (vWA) like domain, central ß-barrel domain and a
divergent C terminal helical region (20). The Ku dimer forms an asymmetrical ring lined
with positively charged and hydrophobic residues that can accommodate the doublestranded DNA backbone independent of sequence (21). Following the introduction of a
DSB, Ku rapidly binds the broken end and forms a complex with the PI3K-like kinase
DNA-PKcs to recruit other NHEJ repair factors and facilitate repair of the break (22). Ku
also has important functions in telomere maintenance and protection, and Ku-deficiency
leads to telomere defects (23, 24).
There is increasing evidence that the Ku N-terminal regions play important roles
in NHEJ as well as in telomere maintenance and apoptotic signaling. Ku70 residues
D192/D195 in Helix 5 of the vWA domain are essential for NHEJ and cell survival
following DNA damage (25-27). Other lysine residues nearby, K160 and K164, have
been shown to confer lyase activity and are involved in DNA processing during NHEJ
(28, 29). The Ku70 and Ku80 N-terminal domains have structural similarities with the
von Willebrand A (vWA) domain, an ancient, evolutionarily conserved domain that is
found in several extracellular and intracellular proteins, where it mediates protein-protein
interactions (30). Indeed Ku forms numerous protein interactions during NHEJ and other
processes, and some of these map to the vWA domain (19). Examples include the NHEJ
factor Aprataxin and PNKP-like Factor (APLF), which binds to the Ku80 vWA domain,
and the Telomere Repeat Binding Factor 2 (TRF2), which interacts with the Ku70 vWA
domain (26, 31).
Our previous investigation focused on identifying key residues in the Ku70 vWA
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domain involved in the cellular response to DNA damage (25). We demonstrated that
mutation of Ku70 serine 155 to alanine increased survival and decreased apoptotic
activation following DNA damage, relative to wild-type (WT) Ku70 despite having no
impact on DNA repair efficiency. Furthermore, this mutation prevented the activation of
a DDR, dependent upon Activating Transcription Factor 2 (ATF2). Since this residue was
a serine, a common site for phosphorylation in the DDR, we hypothesized that this
mutation was preventing a phosphorylation event. Indeed, a phosphomimetic substitution
of S155 to aspartic acid (S155D) constitutively activated ATF2 and conferred a severe
hypersensitivity to IR.
In the present study, we demonstrate that Ku70 S155 is indeed phosphorylated
after IR, and show that constitutive expression of the phosphomimetic mutant Ku70
S155D induces a DDR marked by a constitutive activation of ATM and cell cycle arrest
at both the G1/S and G2/M checkpoints. Additionally, we show that Ku70 S155D
interacts with the Aurora B kinase and mediates the inhibition of its kinase activity. The
interaction of WT Ku70 and Aurora B was detected following IR treatment, but not in
absence of DNA damage. We therefore propose that Ku70 is phosphorylated after IR at
serine 155 and this mediates the interaction and inhibition of Aurora B, resulting in
activation of the DDR and cell cycle arrest.

3.2
3.2.1

Materials and methods
Plasmid Expression Constructs

Ku70 WT, S155D and S155A pMSCVpuro constructs were previously described
(25). Ku70 WT, S155D vWA-FLAG pMSCVpuro constructs were produced by
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subcloning the XhoI and EcoRV fragment (aa 1-250) of full length Ku70 into the
pMSCVpuro vector, and then inserting a FLAG tag by oligonucleotide annealing (SigmaAldrich, Oakville, ON).

3.2.2

Cell Culture and Treatments
Immortalized Ku70-/- MEFs were obtained from S. Matsuyama (Case Western,

Cleveland). IMR-90 cells were obtained from ATCC. All cells were cultured in high
glucose Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS) at 37°C in 5% CO2. Ku70-/- MEFs stably re-expressing Ku70 WT
and mutants were generated as previously described (25). To assess proliferation rates,
the Ku expressing MEFs were seeded in triplicate in 6-well dishes. At each time point
cells were trypsinized, counted using a hemocytometer, and the mean number of cells
was determined. Percent growth was obtained by dividing the number of cells at each
time point by the number of cells at day 1. For irradiation experiments, cells were plated
the night before at 50-70% confluency. Irradiations were performed with a Faxitron RX650 at a dose rate of 1.42 Gy/min. For ATM inhibitor treatments, MEFs were incubated
with 10 µM of KU-55933 (Selleck Chemicals, Houston, TX) for 1 hour prior to 4 Gy of
irradiation. For Aurora B inhibitor treatments, MEFs were incubated with 20 µM of
AZD-1152 (Sigma-Aldrich) for 48 hours.

3.2.3

Extracts, Immunoprecipitation, and Western blot analyses
Nuclear Extracts were prepared as described previously (70). For co-

immunopreciptation experiments, extracts were adjusted to 0.15% NP-40 and 100 mM
KCl, and incubated overnight at 4°C with Ku70 antibody (N3H10, Santa Cruz, Santa
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Cruz, CA). Immunoprecipitates were isolated with Pierce Protein G magnetic beads
(ThermoFisher Scientific, Rockford, IL). For Western blot analysis, extracts were
resolved by SDS-PAGE, transferred onto a PVDF (Polyvinylidene fluoride) membrane
and hybridized with the following antibodies: β-actin (I-19, Santa Cruz), Ku70 (N3H10,
Santa Cruz), p21 (C-19, Santa Cruz), phospho-serine 1981 ATM (Pierce, ThermoFisher
Scientific), ATM (Pierce, ThermoFisher Scientific), phospho-serine 10 Histone H3 (Cell
Signaling, Danvers, MA), Aurora B (H-75, Santa Cruz), FLAG (Sigma-Aldrich). The
blots were developed using the Clarity Western ECL substrate (Bio-rad, Hercules, CA)
and imaged on the Molecular Imager® ChemiDocTM XRS system (Bio-Rad).
Quantifications were performed using Image Lab software (Bio-Rad).

3.2.4

Aurora B Kinase Assay
Immunoprecipitation was performed as described above with the Aurora B

antibody (H-75, Santa Cruz). Immunoprecipitates were resuspended in kinase buffer (20
mM Tris-HCl, 20 mM KCl, 20 mM MgCl2, 0.4 µM ATP, 0.4 mM DTT) and incubated
with 1 µg of purified Histone H3.1 (Cell Signaling) for 1 hour at 37°C. Phosphorylation
was detected by western blot with a phospho-H3S10 antibody (Cell Signaling).

3.2.5

β-Galactosidase Senescence Assay
IMR-90 Cells were plated on 35mm dishes or on glass coverslips in 24-well

dishes. Cells were washed three times with Phosphate Buffer Saline (PBS) and fixed with
4% paraformaldehyde for 15min at 4°C. The staining solution (40mM citric acid/Na
phosphate buffer, 5mM K4[Fe(CN)6] 3H2O, 5mM K3[Fe(CN)6], 150mM NaCl, 2mM
MgCl2, 1mg ml-1 X-Gal (Bioshop Canada Inc, Burlington, ON) in DMSO, pH 6.0) was
added to each dish and incubated for 12-16h at 37°C. Cells were viewed by bright field
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microscopy. Pictures were taken and blue cells cells were counted as a percentage of total
cells.

3.2.6

Reverse Transcriptase PCR (RT-qPCR)
Total RNA was isolated using the Qiagen RNeasy RNA extraction kit. RNA (2

µg) was reverse transcribed with the Superscript II cDNA kit (Invitrogen, ThermoFisher
Scientific). Quantitative PCR was performed using Bio-Rad MyiQ single-color real-time
PCR detection and the Bio-Rad IQ SYBR green mix. The relative quantification of
specific gene expression was determined by the ΔΔCT method, with the target gene
threshold cycle (CT) values normalized to that of the beta-2-microglobulin control.
Primers are listed in Figure E4.

3.2.7

Cell Cycle Analysis by Fluorescence Activated Cell Sorter
(FACS)
Cells were incubated with 10 µM EdU for 1 hour then collected by trypsinization

at a final concentration of 1 × 107 cells/ml. The samples were processed using the EdU
Click-It Alexa 647 Flow cytometry kit (Invitrogen) then stained in 0.1% Triton X-100
(Sigma-Aldrich), 0.2 mg/mL DNase-RNase A (Sigma-Aldrich), and 20 ug/mL of
propidium iodide (Sigma-Aldrich). Cell cycle FACS was performed on a Calibur II (BD
Biosciences, Mississauga, ON) and 50,000 gated events were measured per sample. Cell
cycle modeling and statistics were performed on FlowJo software. All procedures were
performed at the London Regional Flow Cytometry Facility.
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3.2.8

Immunofluorescence
Cells were seeded at 60-80% confluence on 10 mm glass coverslips, washed in

cold PBS and fixed in 3% paraformaldehyde. Cells were permeabilized in 0.5% Triton-X
and blocked in 5% FBS, followed by incubation with primary antibodies: phospho-serine
139 H2AX antibody (Abcam, Cambridge, UK), phospho-serine 1981 ATM (Pierce),
Histone H3 phospho-serine 10 (Cell Signaling), 53BP1 (Pierce) and then with AlexaFluor
488/555/647 secondary antibodies (Invitrogen). All coverslips were mounted onto glass
slides using ProLong Gold containing DAPI (Invitrogen). Cell pictures were taken with
an Olympus BX51 microscope at 40x magnification using the Image-Pro Plus software
(Media Cybernetics, Inc., Bethesda, MD). For γ-H2AX, 53BP1 and phospho-H3S10
analyses, cells were scored for the presence of foci, with DAPI nuclei staining used for
total cell count. Foci-containing cells were quantified as a percentage of total cells, and
approximately 500 cells were counted for each experimental condition per experiment.
The in situ proximity ligation assay (PLA) was performed with the Duolink
(Olink Biosciences, Uppsala, Sweden) kit as per manufacturer instructions with minor
modifications. MEFs were plated at 50-70% confluency onto 10 mM glass coverslips
containing a hydrophobic wax boundary. Coverslips were fixed and permeabilized as
described above and incubated overnight with Ku70 (Santa Cruz) and Aurora B (Santa
Cruz) primary antibodies. Immunofluorescence images were obtained as described
above. DAPI nuclei staining was used for total cell count and PLA signal was quantified
by pixel density measurement in Image J software. The pixel density of the PLA was
normalized to total cell count to obtain a mean PLA signal per cell. These measurements
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were then normalized to the background signal obtained in Ku70-/- MEFs control
samples.

3.2.9

Mass spectrometry and Protein Identification
For phosphorylation identification, 70% confluent MEFs were mock-treated or

treated with 40 Gy of IR and incubated for 30 minutes. 10 mg of nuclear extracts were
adjusted to 100 mM KCl, 2% NP-40 and immunoprecipitated as described above with a
Ku70 antibody (Santa Cruz). Immunoprecipitates were boiled in 1X SDS loading buffer
(2% SDS, 2mM DTT, 5% Glycerol, 40 mM Tris-HCl, 0.01% bromophenol blue), run on
an SDS-PAGE gel and stained with Coomasssie Blue G-250 (Protea Biosciences,
Morgantown, WV).
For peptide pull-down and protein identification, 4 mg of untreated or 10 Gytreated MEF extracts were incubated for 2 hours with one of the following N-terminal
biotin-conjugated

peptides

(Genscript,

Piscataway,

NJ):

biotin-

EVLWVCANLFADVQFKMSH, biotin-EVLWVCANLFDDVQFKMSH. 10 µg of
peptide was pre-coupled to 40 µl of Steptavidin beads (Invitrogen) for 30 min at room
temperature. Pre-coupled beads and extracts were incubated for 2 hours at 4°C. Beads
were washed in (Tris buffer saline, 0.1% Tween20), boiled in 1X SDS loading buffer and
run on SDS-PAGE gel. Gels were stained with the Silver Stain Plus Kit (Bio-Rad) as per
manufacturer instruction.
In-gel digestion was performed using a MassPREP automated digester station
(PerkinElmer, Waltham, MA). Gel pieces were Coomassie de-stained using 50 mM
ammonium bicarbonate and 50% acetonitrile or silver de-stained using a 50 mM sodium
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thiosulphate 5 hydrate and 15 mM potassium ferricyanide solution, which was followed
by protein reduction using 10 mM dithiotreitol (DTT), alkylation using 55 mM
iodoacetamide (IAA), and tryptic or chymotryptic digestion. Peptides were extracted
using a solution of 1% formic acid and 2% acetonitrile and lyophilized. Prior to mass
spectrometric analysis, dried peptide samples were re-dissolved in a 10% acetonitrile and
0.1% TFA (trifluoroacetic acid) solution.
Mass Spectrometry data were obtained using an AB Sciex 5800 TOF/TOF
System, MALDI TOF TOF (Framingham, MA, USA). Data acquisition and data
processing were respectively done using a TOF TOF Series Explorer and Data Explorer
(AB Sciex). The instrument is equipped with a 349 nm OptiBeam On-Axis laser. The
laser pulse rate is 400 Hz. Reflectron positive mode was used. Reflectron mode was
externally calibrated at 50 ppm mass tolerance and internally at 10 ppm. Each mass
spectrum was collected as a sum of 400 shots. MALDI matrix, α–cyano–4–
hydroxycinnamic acid (CHCA), was prepared as 5 mg/mL in 6mM ammonium phosphate
monobasic, 50% acetonitrile, 0.1 % trifluoroacetic acid and mixed with the sample at 1:1
ratio (v/v). All procedures were performed at the London Regional Proteomics Centre
(LRPC).

3.2.10

Statistical Analyses

Differences between multiple groups was determined an analysis of variance
(ANOVA) and differences between two groups was determined by an unpaired two tail ttest. Results were considered significant when P< 0.05.
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3.3
3.3.1

Results
Ku70 S155 is phosphorylated in response to DNA damage

We previously established a retroviral system using a murine stem cell virus
construct (pMSCV) to stably re-express WT Ku70 and Ku70 mutants in immortalized
Ku70-deficient mouse embryonic fibroblasts (Ku70-/- MEFs). Using this system, we
determined that MEFs expressing Ku70 S155 amino acid substitutions exhibited altered
survival following IR treatment (25). A mutant Ku bearing a Ku70 S155 substitution to
alanine (Ku70 S155A) enhanced survival following IR treatment, causing a DNA damage
signaling defect and compromising the activation of apoptosis in response to DNA
damage. In contrast, substitution to a phosphomimetic residue (S155D) conferred
hypersensitivity to IR treatment. These analyses suggested that S155 is a phosphorylation
site that is targeted for phosphorylation in response to DNA damage. To determine
whether this site is phosphorylated following DNA damage, we conducted Mass
Spectrometry (MS) analyses on Ku70 immunoprecipitated from nuclear extracts obtained
from WT Ku70-expressing MEFs either untreated, or 30 minutes following a 40 Gy IR
treatment. Chymotryptic digestion of immunoprecipitated Ku peptides revealed a peak
corresponding to a peptide doubly phosphorylated at positions S155 and S162 in the
irradiated sample, but not in the unirradiated control samples (Supplementary Figure 31B). To confirm these results, we repeated the analysis with extracts obtained from Ku70
S155A-expressing MEFs. In this case, only a mono-phosphorylated peptide was
observed, consistent with the mutation preventing phosphorylation at S155 and being
solely phosphorylated at S162 (Supplementary Figure 3-1C). Thus, we repeated the
procedure with MEFs expressing a Ku70 mutant bearing an alanine substitution at
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position S162. Again, only one peak corresponding to the mono-phosphorylated peptide
was observed, suggesting that this peptide was now only phosphorylated at the S155
position (Supplementary Figure 3-1D). Neither control samples obtained from Ku70
S155A or S162A expressing MEFs contained a peak corresponding to a peptide with
phosphorylated S155. Overall these results suggest that Ku70 is phosphorylated at S155
after IR.

3.3.2

Ku70 S155D induces cell cycle arrest
While the expression of the Ku70 S155D mutant in Ku70-/- MEFs led to a strong

hypersensitivity to IR (25), we also noted that Ku70 S155D-expressing MEFs
proliferated abnormally under standard culturing conditions. Growth rate analysis in the
absence of any DNA damaging agent showed that expression of Ku70 S155D conferred a
marked defect in proliferation, as these cells exhibited a 5.7-fold decrease in percent
growth compared to Ku70-/- MEFs re-expressing Ku WT by the fifth day of culture, and
were even 3.6-fold slower than Ku70-/- MEFs, which have been previously reported to
have proliferation defects (32) (Figure 3-1A). In contrast, the Ku70 S155A expressing
MEFs proliferated faster than the WT counterparts, achieving a 1.8-fold increase over
Ku70 WT MEFs by the fifth day of culture. In order to further analyze this proliferation
defect, we compared the cell cycle profile of Ku70 WT, S155D, S155A cells and Ku70-/MEFs (Figure 3-1B). Fluorescence activated cell sorting (FACS) analysis of Ku70
S155D-expressing MEFs showed that 46% of cells were in G1 phase, higher than the
approximately 30% seen in the other three cell lines. Similarly, 27% of Ku70 S155Dexpressing MEFs were in the G2 phase, higher than the approximately 8% seen in the
WT, S155A and Ku70-/- cells (Figure 3-1B). Altogether this indicates that the Ku70
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Figure 3-1 Expression of Ku70 S155D triggers cell cycle arrest
(A) Ku70 S155 mutants confer altered cell proliferation. Growth rates of Ku70-/- MEFs
expressing Ku70 WT, S155A, S155D or empty vector were assessed for 5 days. Data
represents percent growth relative to Day 1 of three independent experiments with error
bars indicating SEM (*P<0.05, all cell lines compared to WT). (B) Ku70 S155D cells
arrest in G1 and G2. FACS analysis of DNA content and EdU incorporation in
asynchronous Ku70-/- MEFs expressing Ku70 WT, S155A, S155D or empty vector
(Ku70-/-) stained with propidium iodide and Anti-Edu Alexa 647. Average percentage
was determined by FlowJo cell cycle analysis in three separate experiments with error
bars indicating SEM (*P<0.01 S155D compared to all other cell lines).
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serine 155 residue regulates cellular proliferation and the expression of the
phosphomimetic S155D mutation induces cell cycle arrest at both the G1/S and G2/M
checkpoints.
In order to analyze the global transcriptional changes that resulted in cell cycle
arrest, an Affymetrix GeneChip was performed using RNA from Ku70-/-MEFs expressing
Ku70 WT and S155D. Several genes were either up- or downregulated in the Ku70
S155D-expressing MEFs relative to WT control (Supplementary Table 3-1), and
subsequently, some were validated by RT-qPCR (Figure 3-2A). Cyclin D and CDK6, two
proteins that form a complex to promote the progression through the G1/S checkpoint
and Cyclin B, whose expression increases during the G2/M transition (33), were found
5.1-, 13.7-, and 7.2-fold downregulated, respectively, in Ku70 S155D-expressing MEFs.
Similarly, expression of Protein phosphatase 1 (PP1), a serine/threonine phosphatase,
involved in the dephosphorylation of several targets during the DDR to resolve DNA
damage checkpoints (34), was 28.8-fold downregulated in Ku70 S155D-expressing
MEFs. Finally, the X-linked inhibitor of apoptosis-associated factor 1 (XAF-1), which
regulates apoptosis and G2/M arrest (35, 36), was upregulated by 5.1-fold in Ku70
S155D MEFs. We also assessed the protein levels of p21, an inhibitor of cyclin D and BCDK complexes which is upregulated in a p53 dependent manner following DNA
damage and activates the G1 and G2 cell cycle checkpoints (37, 38). Western blot
analysis showed that while Ku70 WT MEFs required IR treatment to induce expression
of p21, Ku70 S155D cells displayed a marked upregulation of p21 in the absence of any
treatment (Figure 3-2B). Conversely, the Ku70 S155A MEFs failed to upregulate p21
levels, even after IR treatment (Figure 3-2C). Overall, consistent with the observation
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Figure 3-2 Ku70 S155D-expressing MEFs display altered expression of cell cyclerelated factors.
(A) RT-PCR analysis of Cyclin D, Cyclin B, CDK6, PP1 and XAF-1 gene expression.
RNA samples from WT or S155D Ku70-expressing MEFs were analyzed by RT-qPCR
using primer sets specific for the indicated genes. The fold change in gene expression of
Ku70 S155D relative to Ku70 WT MEFs is shown, with error bars indicating SEM
(**P<0.01, *P<0.05). (B) Comparison of p21 expression in Ku70 WT and mutant MEFs.
Representative western blot analysis of p21 in Ku70 WT and S155D expressing MEFs
without IR (above) and p21 induction at the time points indicated after 10 Gy of IR in
Ku70 WT and S155A MEFs (below). Similar amount of extracts were loaded on both
gels (30 µg). Due to the strong expression of p21 in the Ku70 S155D MEFs, the western
blot on the left required only a 30-second exposure, compared to a 10-minute exposure
for the western blot on the right required to obtain a similar intensity of p21 signal in
response to DNA damage. Exposure time for the actin signal is similar for both western
blots.
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that the expression of Ku70 S155D results in the arrest of cells in the G1 and G2 phases,
this mutant alters the expression of cyclins known to regulate the progression through
both the G1/S and G2/M checkpoints, and markedly upregulates the cell cycle inhibitor
p21.

3.3.3

Ku70 S155D induces a DNA damage response
We previously determined that an alanine substitution at Ku70 S155 decreased

activation of apoptosis via an ATF2-dependent DDR pathway following IR treatment
(25). The altered proliferation of Ku70 S155 mutant-expressing MEFs however, was
occurring in the absence of any DNA damaging agent, and it was not clear whether this
phenotype was related to the DDR defect observed previously, or if it was a direct effect
of Ku on the cell cycle. To test this, we examined the presence of active DNA damage
response markers following the expression of Ku70 S155 mutants. Surprisingly,
immunofluorescence (IF) analysis of Ku70 S155D-expressing MEFs showed
significantly increased ϒ-H2AX and 53BP1 foci formation compared to both Ku70 WT
and S155A-expressing MEFs, in the absence of any DNA damage treatment (Figure 33A,B). Furthermore, western blot analysis for activated ATM, marked by an autophosphorylation at serine 1981, showed increased levels (relative to WT) in untreated
S155D MEFs, while S155A MEFs had very little activation of ATM after even IR
(Figure 3-3C). Interestingly, pre-treatment of cells with the ATM inhibitor KU-55933
prevented activation of ATM after IR in Ku70 WT and S155A MEFs, but had no impact
on ATM activation in Ku70 S155D MEFs, suggesting that in these cells, ATM is
constitutively phosphorylated at least to the same levels as those reached in response to
10 Gy of IR (Figure 3-3C) (39). Overall, these observations suggest that expression of the
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Figure 3-3 Ku70 S155D expression induces a DNA damage response in the absence
of DNA damage.
(A) Cells were analyzed by immunofluorescence with a Υ-‐H2AX antibody with
representative pictures shown (left). Foci-containing cells were quantified and shown as
an average of three experiments with error bars indicating SEM (right) (**P<0.01,
*P<0.05). Scale bars, 10 µm. Cells were scored positive when containing more than 5
foci.

(B) Same procedure as in A, but the analysis was performed with a 53BP1

antibody. (C) Western blot analysis of p-S1981 ATM in Ku70 S155D, WT and S155A
expressing MEFs. Samples were either left untreated (control), collected 30 minutes
following 10 Gy of IR (IR), or collected 30 minutes after 10 Gy of IR following a 1 hour
incubation with 10 µM ATM inhibitor (ATMi). Quantification of four separate
experiments is shown (below) with error bars indicating SEM.

140

141

136

142

phosphomimetic Ku70 S155D constitutively activates an ATM-dependent DNA damage
response pathway, in the absence of ectopically-induced DNA damage.

3.3.4

Ku70 S155D vWA domain is sufficient to induce cell cycle
arrest
Ku is well characterized as a DNA binding protein functioning in both DNA

repair via the NHEJ pathway and the protection of telomere ends (19). Although it
appeared as though the Ku70 S155D mutation induced a constitutive signal for the DDR,
the signaling mechanism was unclear. In order to test whether the DNA binding activity
of Ku was needed to produce the DDR induced by Ku70 S155D, we generated truncated
Ku70 Flag-tagged constructs containing only the vWA domain, either with the WT
sequence or with the S155D substitution. The central ring domain is required for
Ku70/Ku80 heterodimerization and DNA binding activity, so a truncated Ku70 construct
containing only the vWA domain cannot fulfill either function (20). Similar to the fulllength (FL) Ku70 S155D construct, the expression of the S155D vWA domain in Ku70-/MEFs significantly decreased proliferation, as by the fifth day the Ku70 S155D vWA
MEFs had a 16.4-fold lower proliferation rate as compared to the Ku70-/- MEFs
expressing Ku70 WT vWA domain control (Figure 3-4A). Also, consistent with what
was observed previously with Ku70 S155D, western blot analysis demonstrated a marked
upregulation of p21 levels in Ku70 S155D vWA MEFs compared to Ku70 WT vWA
control cells (Figure 3-4C). This suggests that recruitment of the Ku70 S155D mutant to
DNA is not required to induce a DDR. These results were obtained in a Ku70 null
background, so we sought to determine whether the Ku70 S155D mutation would have a
dominant effect in a cell line that had normal Ku70 expression. Expression of the
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Figure 3-4 N-terminal Ku70 S155D domain is sufficient to induce a DDR and cell
cycle arrest.
(A) Growth rates of Ku70-/- MEFs expressing Ku70 WT or S155D vWA domain
constructs were assessed for 5 days. Data represent percent growth relative to Day 1 of
three independent experiments with error bars indicating SEM (*P<0.05 compared to
WT). (B) Growth rates of IMR-90 cells were assayed as described above, for 10 days.
(C) Western blot analysis of p21 levels in IMR90 and Ku70-/- MEFs expressing either
Ku70 WT or S155D vWA domain. (D) IMR-90 cells expressing Ku70 WT or S155D
vWA domain truncated constructs were stained with a solution containing X-gal (5bromo-4-chloro-3-indolyl-β-D-galactopyranoside). Senescence induced over expression
of the β-galactosidase enzyme cleaves X-gal to produce a blue dye observed in bright
field microscopy. The percentage of cells stained blue were quantified and shown as an
average of three experiments with error bars representing SEM (*P<0.05). Scale bars, 10
µm.
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retroviral Ku70 vWA-only constructs in the human cell line IMR-90 produced similar
results, with the Ku70 S155D vWA domain significantly reducing proliferation by 3-fold
compared to the Ku70 WT vWA domain at the tenth day of culture (Figure 3-4B). Again,
a marked upregulation of the p21 protein levels in the S155D vWA-expressing IMR-90
cells was observed compared to WT vWA as measured by western blot (Figure 3-4C).
Additionally, in this cell line, a senescence phenotype was observed (4), as a significantly
increased level of beta-galactosidase activity was found in S155D expressing cells
relative to WT (Figure 3-4D). Overall, the Ku70 S155D vWA domain does not require
heterodimerization with Ku80 nor end-binding capabilities to induce cell cycle arrest and
this phenotype is dominant to WT Ku.

3.3.5

Ku70 S155D interacts with and inhibits Aurora B
Given that the Ku70 S155D vWA domain lacking both its DNA binding domain

and the ability to heterodimerize with Ku80 induced cell cycle arrest, we hypothesized
that this domain was acting by binding to another factor(s) and either constitutively
activating or inhibiting its activity. A general screen for interacting factors was performed
using biotin-conjugated peptides of the loop region surrounding S155 (aa 145 to 163) and
comparing factors that bound to peptides containing either an alanine or aspartic
phosphomimetic mutant at the serine 155 position. S155A or S155D peptides were
incubated with MEF nuclear extracts from cells that were either untreated or subjected to
10 Gy of IR. Interacting factors were pulled down with streptavidin beads and identified
by mass spectrometry.
MS analysis identified Aurora B as a factor interacting with the S155D peptide in
control and IR-treated extracts (Supplementary Figure 3-2). The interaction of Aurora
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B with the S155D peptide was validated using pull-down of WT MEF extracts with S155
A/D peptides followed by western blot analysis (Figure 3-5A). We then verified the
interaction

between

Aurora

B

and

full

length

Ku70

S155D.

Ku70

was

immunoprecipitated from nuclear extracts from Ku70-/- MEFs (used as a control), and
Ku70-/- MEFs re-expressing WT Ku70 or Ku70 S155D. Endogenous Aurora B was
efficiently co-immunoprecipitated with Ku70 S155D, indicating that Aurora B interacts
with the phosphomimetic form of Ku70 (Figure 3-5B). However, very little Aurora B
was observed in the WT Ku70 immunoprecipitates, suggesting that phosphorylation of
S155 is needed for interaction between the two proteins.
Aurora B, a member of the serine/threonine family of Aurora kinases, promotes
the progression of the cell cycle through the G1/S, G2/M and mitotic checkpoints by the
phosphorylation of several targets (5). Interestingly, studies examining the potential for
Aurora B inhibitors in cancer therapy showed that chemical inhibition of Aurora B results
in cell cycle arrest and the activation of several DDR markers, notably ϒ-H2AX and
53BP1, ATM S1981 phosphorylation and upregulation of p21 (15, 16). Thus, the effects
of Ku70 S155D expression appeared to be similar to those reported in response to Aurora
B inhibition, suggesting the possibility that interaction between Ku70 S155D and Aurora
B could inhibit Aurora B.
First we investigated whether inhibition of Aurora B in Ku70 WT MEFs produced
the same cellular response as that observed in MEFs expressing the Ku70 S155D mutant.
Treatment of WT MEFs with 20 µM of the Aurora B selective inhibitor AZD-1152 (40)
for 48 hours triggered a marked upregulation of the cell cycle inhibitor p21 relative to
control (vehicle-treated) samples as measured by western blot analysis (Figure 3-6A).
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Figure 3-5 Ku70 S155D interacts with Aurora B.
(A) Aurora B interacts with a Ku70 S155D peptide. Biotin-conjugated peptides of the 15
amino acids surrounding Ku70 S155 containing either a S155A or S155D substitution
were used in a biotin-streptavidin pull-down with untreated WT Ku70 MEF extracts.
Shown is a western blot analysis of Aurora B present in the samples pulled-down with
the indicated peptides. (B) Interaction of Aurora B with Ku70 S155D. Extracts from
Ku70-/- MEFs stably expressing Ku70 WT, Ku70 S155D or empty vector were
immunoprecipitated with a Ku70 antibody. The immunoprecipitates were analyzed by
western blot with antibodies against Ku70 and Aurora B.
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Figure 3-6 Aurora B chemical inhibition induces a DNA damage response.
(A) Western blot analysis of p21 and p-S1981 ATM levels in WT Ku70 MEFs treated for
48h with either 20 μM of the Aurora B inhibitor AZD-1152 (+) or the DMSO vehicle
control (-). (B) RT-PCR analysis of Cyclin B, CDK6, Cyclin D and XAF-1 in WT Ku70
MEFs treated with Aurora B inhibitor as described in A, normalized to the DMSO
vehicle control (*P<0.05). (C) Immunofluorescence analysis of γ-‐H2AX and 53BP1 foci
formation in MEFs treated with either AZD-1152 or the DMSO vehicle control as
described above. Cells were scored positive when containing more than 5 foci and the
results shown are averaged from three experiments with error bars indicating SEM
(*P<0.05). Scale bars, 10 µm.
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Next, we looked at the effect of Aurora B inhibition on the expression of the
genes that we found deregulated in cells expressing Ku70 S155D. RT-PCR analysis of
RNA extracted from Ku70 WT-expressing MEFs treated with AZD-1152 revealed,
similar to what was observed in Ku70 S155D-expressing cells, Cyclin B, Cyclin D and
CDK6 expression was significantly downregulated relative to the vehicle control-treated
cells (Figure 3-6B). Lastly, we investigated the effect of Aurora B inhibition on the
activation of the DDR. Immunofluorescence analysis of ϒ-H2AX and 53BP1 foci
formation revealed that treatment of Ku70 WT MEFs with AZD-1152 significantly
increased both 53BP1 and ϒ-H2AX foci (Figure 3-6C). Western blot analysis also
showed an increase in ATM activation in the AZD-1152-treated samples, as determined
by the pS1981-ATM levels (Figure 3-6A). Thus, Aurora B inhibition induced a DNA
damage response and transcriptional changes that mirrored those induced by Ku S155D
expression.
Since Ku70 S155D-expressing MEFs display cell cycle arrest and activation of a
DNA damage response, a phenotype observed in Aurora B inhibitor-treated MEFs, we
hypothesized that Ku70 S155D interaction with Aurora B could be inhibiting the activity
of Aurora B. To explore the impact of Ku70 S155D expression on Aurora B kinase
activity, we monitored phosphorylation of histone H3 on serine 10 (H3S10), which is
catalyzed by Aurora B (9, 41, 42). Immunofluorescence analysis of phospho-H3S10 in
MEFs expressing either WT or Ku70 S155D revealed that Ku70 S155D expression led to
significantly decreased H3S10 phosphorylation compared to WT (11% of phosphoH3S10 foci-containing cells versus 43% in S155D) (Figure 3-7A). However, although
this result showed that the Ku70 S155D expression led to the loss of a specific Aurora B
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Figure 3-7 Ku70 S155D inhibits Aurora B kinase activity.
(A) Immunofluorescence analysis of phospho-H3S10 foci formation in Ku70 WT and
S155D-expressing MEFs. Foci-positive cells were counted as a percentage of total cells
and shown is the average of three experiments with error bars indicating SEM (*P<0.05).
Scale bars, 10 µm. (B) Aurora B kinase activity assay. Ku70 WT or S155D-expressing
MEF nuclear extracts were immunoprecipitated with an Aurora B antibody or IgG
control. The immunoprecipitates were then incubated with 1 µg of purified Histone H3
and 10 µM of ATP and analyzed by western blot with antibodies to phospho-H3S10,
Aurora B and Ku70. Phospho-H3S10 western blot signal was quantified and shown as an
average of three separate experiments with error bars indicating SEM (*P<0.05)
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phosphorylation event, the loss of H3S10 phosphorylation would be expected to happen
in cells experiencing prolonged cell cycle arrest and no longer undergoing mitosis. To
show that this was not the result of cell arrest, but a direct effect of Ku70 S155D on
Aurora B kinase activity, we carried out an in vitro assay in which endogenous Aurora B
was immunoprecipitated from either Ku70 WT or S155D-expressing MEFs and
incubated with purified histone H3. Western blot analysis using an antibody directed
against

phosphorylated

H3S10

detected

phosphorylation

with

Aurora

B

immunoprecipitates from Ku70 WT-expressing MEFs in this assay (Figure 3-7B).
However,

phosphorylation

of

H3S10

was

significantly

lower

(2.9-fold)

in

immunoprecipitates from Ku70 S155D-expressing MEFs, suggesting that complex
formation of Aurora B and Ku S155D has an inhibitory effect on Aurora B kinase
activity (Figure 3-7B).

3.3.6

Ku70 and Aurora B interact following DNA damage
Thus far, our results indicated that Ku70 S155 was phosphorylated in response to

IR and that Ku70 comprising the phosphomimetic substitution S155D interacted with and
inhibited the activity of Aurora B. These data led us to speculate that in vivo, Ku70
phosphorylation after IR could function to inhibit the activity of Aurora B and prevent
cell cycle progression, potentially leading to the activation of cell cycle checkpoints and
senescence. In order to test this model, we sought to determine if Ku70 and Aurora B
interact following IR treatment. Since the localization of Ku to DSBs is difficult to
observe directly by microscopy (43), we employed a proximity ligation assay (PLA), a
method that was developed to monitor interactions of endogenous proteins directly in
individual cells by immunofluorescence (44). Briefly, following incubation with primary
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antibodies against the two proteins of interest, cells are incubated with secondary
antibodies linked to short DNA oligonucleotides, called PLA probes. When two PLA
probes come into close proximity, (within 40nm) they serve as a template for rollingcircle DNA synthesis, resulting in a PLA signal in the form of a dot by fluorescence
microscopy analysis. Each protein-protein interaction is represented as a fluorescent dot
which can be visualized by fluorescence microscopy. PLA was performed in Ku70-/MEFs re-expressing either Ku70 WT or Ku70 S155A with antibodies directed against
both Ku70 and Aurora B (Figure 3-8A). In untreated samples, few dots were detected in
either the Ku70 WT or S155A-expressing cells. However, in cells treated with 10 Gy of
IR, a significant increase in the number of dots was observed in the Ku70 WT-expressing
MEFs, while no change was detected in the Ku70 S155A-expressing MEFs. These results
suggest that while Ku70 and Aurora B do not associate in normally proliferating cells, a
complex is formed following the introduction of DNA damage. This interaction is
dependent upon the phosphorylation of Ku70 at S155, as it is not observed in the S155A
samples, where the residue is not phosphorylated.
We next investigated the effect of Ku70 S155 mutations on Aurora B activity
following IR, as measured by phospho-H3S10 foci formation. In Ku70 WT-expressing
MEFs, a decrease in H3S10 phosphorylation was observed 2 hours following IR
treatment (36% of foci-containing cells down to 21%) suggesting a decrease in Aurora B
activity (Figure 3-8B). In Ku70 S155A-expressing MEFs, however, no significant
difference in the phospho-H3S10 levels was not detected between control and irradiated
(2h) samples suggesting that Aurora B activity was not reduced in these cells. This
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suggests that Ku phosphorylation on Ku70 S155 in response to DNA damage functions to
promote its interaction with Aurora B and inhibits its kinase activity.
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Figure 3-8 Ku70 interacts with Aurora B after IR and Aurora B inhibition after IR
is dependent on Ku70 S155 phosphorylation.
(A) Interaction of Aurora B and Ku after DNA damage using Proximity Ligation Assay
(PLA). Ku70 WT and S155A expressing MEFs were left untreated or were treated with
10 Gy of IR and fixed after a 30-minute incubation. Cells were incubated with antibodies
to Ku70 and Aurora B and processed for PLA analysis. Shown are representative
immunofluorescent images. Green dots represent the PLA signal, the nuclei are stained
with DAPI. Interactions were quantified by pixel density and shown as an average of
three experiments with error bars indicating SEM. (*P<0.05). Scale bars, 10 µm. (B)
Immunofluorescence analysis of phospho-H3S10 in Ku70 WT and S155A-expressing
MEFs that were either left untreated, or were treated with 10 Gy of IR and incubated for
2 hours. Foci-positive cells were counted as a percentage of total cells and results are
shown as an average of three experiments with error bars indicating SEM (*P<0.05).
Scale bars, 10 µm.
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3.4

Discussion

This study identifies serine 155 of Ku70, as a novel phosphorylation site
following DNA damage. Through expression of a phosphomimetic S155D mutant, we
demonstrated that this phosphorylation event induces a DDR and cell cycle arrest. We
found that Ku phosphorylated at Ku70 S155 interacts with the Aurora B kinase and
inhibits its activity, suggesting that the DNA damage signaling events activated by Ku70
S155D occur through Ku’s modulation of Aurora B kinase activity.
Expression of a phosphomimetic substitution at the serine 155 site into Ku70-/MEFs induces a potent DDR leading to cell cycle arrest and senescence. This is in
contrast to what is observed with cells expressing Ku70 with an alanine substitution at the
S155 site, which exhibit increased growth rate, increased survival and decreased
activation of DNA damage markers after IR. These opposing phenotypes led us to
hypothesize that S155 is modified and that the alanine substitution prevents a
phosphorylation event that dictates cell survival following DNA damage. Phosphorylated
Ku has been observed in large scale and in vitro proteomic studies, in a number of
different contexts and cell types. These include human Hela and K562 cancer cell lines,
and upon mTOR-dependent signaling, stem cell differentiation and, interestingly, mitotic
kinase inhibition (45-49). However in many cases functional significance of this
phosphorylation could not be demonstrated. For example, alanine substitutions of several
residues phosphorylated by DNA-PK in vitro had no impact on NHEJ efficiency (50, 51).
Interestingly, some of these same residues, located in the Ku70 N-terminus, were deemed
essential for apoptotic activation in neurons (52). Here, we demonstrate that
phosphorylation of Ku70 on serine 155 is a DNA damage-induced event that modulates
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cell fate decisions. The fact that S155 phosphorylation was not detected in previous
proteomic studies could be due to low abundance of the pS155 peptide. We propose that
S155 phosphorylation occurs on those Ku molecules actively involved in NHEJ at the
break, and in the event of overwhelming damage that requires the activation of apoptosis
or prolonged cell cycle arrest. This would result in very few phosphorylated Ku
molecules relative to the total amount of this highly abundant protein, and would only
occur under very specific conditions. We optimized detection of this residue by treating
cells with a high dose of IR and immunoprecipitating Ku70, but still observed the
phosphorylated peptide in low abundance. Furthermore, the previous proteomics studies
employed proteolytic enzymes other than chymotrypsin and could have been producing
pS155 peptides without a composition favorable for MS detection. It should be noted that
our results also indicate a probable phosphorylation at the S162 position, a site that has
not been reported in these large-scale studies.
It remains to be determined which kinase is responsible for phosphorylating S155
as it does not fall within any canonical kinase motif. Possible candidates include ATM
and DNA-PKCS, which have a loose consensus motif that includes S/TXXQ sequences,
satisfied by the SDVQ sequence of Ku70 (53). Many other possibilities exist however,
due to the abundance of serine/threonine kinases involved in the DDR. Indeed, proteomic
data have implicated the kinases Chk1, CDK2 and Polo-like in Ku phosphorylation (47,
54, 55).
The expression of Ku70 S155D induced a DDR marked by H2AX
phosphorylation, 53BP1 foci accumulation and activation of ATM. This phenotype
correlates with the phenotypes observed in cells treated with Aurora B inhibitors and
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suggests that the effects of Ku S155D are conferred, at least in part, through its inhibition
of Aurora B activity. Studies using the broad Aurora kinase family inhibitors MLN8054,
MK-0457, and VE-465, as well as our own study employing the specific Aurora B
inhibitor AZD-1152, observed γ-H2AX and 53BP1 foci formation, and the activation of
ATM signaling, as measured by ATM phosphorylation (15, 16). AZD-1552 treatment has
been further shown to slow growth rate, induce cell cycle arrest and senescence, and
increase sensitivity to IR, all phenotypes observed following Ku70 S155D expression
(12-14, 56). We also observed some enlarged nuclei in Ku70 S155D-expressing MEFs
(Figure 3-3A), a phenomenon indicative of failed cytokinesis and polyploidy, another
common consequence of Aurora B inhibition (57).
Perhaps the most striking effect of Ku S155D expression is its ability to strongly
activate p21. p21 gene (Cdkn1a) expression was increased in S155D cells (Supplemental
Table 3-1) and p21 protein levels were markedly upregulated. In contrast, in cells
expressing Ku70 S155A, p21 induction was severely attenuated in response to DNA
damage. Aurora B has been suggested to repress p21 expression and Aurora B
downregulation or inhibition was shown to result in p21 upregulation (58, 59). Again,
this is consistent with an inhibitory role for Ku70 S155D on Aurora B activity leading to
p21 activation, and with a lack of repression of Aurora B in Ku70 S155A cells,
preventing p21 induction in response to DNA damage. Interestingly, Kumari et al.
revealed that Aurora B inhibition activates p38 MAP kinase, which in turns promotes p21
induction by promoting transcriptional elongation of p21 transcripts (60). p38 is known
to activate the transcription factor ATF2, which is also found strongly activated in Ku
S155D MEFs (25). In addition, the expression of ATF3, a downstream target of ATF2
161

162

that is upregulated in the Ku70 S155D-expressing cells (Supplemental Table 3-1) is
increased through Aurora B inhibition in a p38-dependent manner (61, 62). Altogether,
the similarities between the effects caused by Aurora B inhibition and Ku70 S155D
expression are consistent with the inhibition of Aurora B by Ku70 S155D.
Expression of a truncated Ku70 S155D comprising only the vWA domain
triggered a similar growth defect in both Ku70-/- MEFs and in the cell line IMR90 which
are non-transformed human lung cells that express normal levels of Ku. This
demonstrates that the Ku70 S155D substitution exerts a dominant-negative effect, and
that Ku70 S155 regulation is not specific to a particular cell line, although the amplitude
of the response may vary depending on cell type. Moreover, it suggests that Ku70 S155D
can exert its effects in absence of DNA binding. Indeed, the Ku70 vWA peptide lacks
both heterodimerization and end-binding activities. However, we cannot exclude that it
interacts with telomeres. How Ku binds to telomeres, whether it is through direct binding
to telomeric DNA or through telomere protein interactions is still a matter of debate (19).
Interestingly, residues in Ku70 vWA domain Helix 5 have been suggested to interact with
the shelterin protein TRF2, however, whether this interaction is sufficient to recruit Ku to
telomeres has not been investigated (26).
The interaction between Aurora B and Ku was dependent on phosphorylation at
S155. We showed that while Ku70 and Aurora B do not interact in normally proliferating
cells, Aurora B does associate with the phospho-form of Ku70, and they form a complex
following DNA damage. Importantly, we found that Aurora B inhibition was dependent
on Ku70 S155 phosphorylation, which suggests that the interaction of Ku pS155 with
Aurora B is required for its inhibition. The full activation of Aurora B is achieved
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through conformational changes induced by the binding of protein cofactors (63). There
are a number of known activators of Aurora B, well characterized examples being the
members of the chromosomal passenger complex (CPC), and this diversity allows for the
specific targeting and local activation of Aurora B to different chromosomal structures
(64). Similarly, inhibition of Aurora B is mediated through protein-protein interactions,
including phosphatases PP1, PP2A and the checkpoint protein BubR1 (64). We propose
that Ku, interacting with Aurora B through its Ku70 vWA domain, is an inhibitory
cofactor following DNA damage. Thereby, the phosphomimetic S155D Ku70 mutant acts
as a dominant negative, by constitutively binding and inhibiting Aurora B, either through
direct hindrance of its catalytic activity or by precluding the interactions with other
activating cofactors.
There is a body of evidence linking DNA repair proteins to the inhibition of
Aurora B kinase activity. Similar to what we observed with Ku70 S155D, the alternative
end-joining DSB repair protein PARP-1, was demonstrated to interact with and inhibit
Aurora B kinase activity, in this case as a result of direct ribosylation of Aurora B (65).
The HR proteins BRCA2/BARD1 were also shown to negatively regulate Aurora B by
promoting its degradation (66). Together with our results, this suggests that several
mechanisms involving factors from the three different DSB repair pathways converge to
inhibit Aurora B activity in response to DNA damage.
Overall, our results suggest that upon the introduction of DNA damage,
unphosphorylated Ku is recruited to DNA breaks where it promotes the assembly of the
NHEJ DNA repair complex. We propose that Ku is phosphorylated at S155 under
conditions of overwhelming damage or when the DNA break is too complex for proper
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repair. This event ensures the sustained activation of the DDR and Aurora B inhibition to
reinforce cell cycle arrest, providing time to complete DNA repair. If repair cannot be
completed, the persistence of Ku70 S155 phosphorylation could contribute to senescence
or activation of apoptotic pathways. Our model implies that Aurora B is recruited to
DNA breaks, which remains to be confirmed. The role of Aurora B in the DDR is still
poorly understood, however, it has previously been linked to prominent regulators of the
DDR, such as the Repo-Man/PP1 complex and ATM (67-69). Our data provide
additional evidence that Aurora B plays an important role in the response of cells to DNA
damage. Our study also reinforces the notion that Ku’s presence at the DNA break not
only serves to recruit the NHEJ machinery, but also functions to relay signals to the DDR
to modulate cellular responses, presumably as a function of DNA repair completion.
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3.6

Supplementary materials

Supplementary Figure 3-1 Identification of S155 phosphorylation.
(A) Theoretical chymotryptic digest of Ku70 amino acids 68-300 obtained from MSDigest (UC San Francisco). Parameters allow 6 missed cleavages and consider oxidation
and serine/threonine phosphorylation. (B) Experimental masses obtained from MALDI
analysis of Ku70 immunoprecipitated from both unirradiated and 30 minutes following a
40 Gy IR treatment WT Ku70 MEF samples were matched to theoretical masses obtained
from MS-Digest. Peptides including Serine 155 highlighted in yellow with amino acid
modifications indicated. (C) Analysis as in B, with MEFs expressing Ku70 S155A. D.
Analysis as in B, with MEFs expressing Ku70 S162A.
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Supplementary Table 3-1 S155D Ku70 induces expression changes in genes
regulating cell cycle and apoptosis.
Samples from WT and S155D Ku70 expressing MEFs were subjected to microarray
analysis using a GeneChip Mouse Gene 1.0 ST Array (Affymetrics, Santa Clara, CA).
GeneChips were processed at the London Regional Genomics Centre (Robarts Research
Institute, London, ON; http://www.lrgc.ca). Shown is the list of genes, organized by
cellular process, identified as differentially expressed in S155D Ku70 MEFs compared to
the WT Ku70 control, with the fold expression change indicated for two separate
experiments.
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Supplementary Figure 3-2 Pulldown of proteins interacting with biotin-conjugated
Ku70 peptides.
(A) Silver stained gel of streptavidin-biotin pulldown of proteins interacting with Ku70
peptide containing either an alanine or aspartic acid substitution at the S155 position. Pull
down was performed in MEF extracts that were either untreated or treated with 10 Gy of
IR and incubated for 30 minutes. Band boxed in red was identified by MS/MS as being
Aurora B. (B) Proteins were subjected to trypsin digestion and peptide masses obtained
from MS/MS analysis. MASCOT (Matrix Science) database results for boxed band with
parameters indicated.
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Supplementary Table 3-2 Primers used in this study.
RT-PCR primer sequences.

178

184

Chapter 4

4

General Discussion
4.1

Summary of findings

Prior to the start of this investigation, there was little known about the
contribution of Ku’s vWA domain to the execution of NHEJ. This domain, named after
the prototypic member, the von Willebrand factor A, frequently functions to mediate
protein-protein interactions. We aimed to identify a possible role for this domain in
response to IR by producing a series of alanine mutants at different positions throughout
the vWA domain. Our hypothesis was that this domain could be mediating interactions
with Ku and other NHEJ factors, so we chose residues that were more likely to
participate in interactions, such as those that were present on the solvent exposed surface
and showed some degree of conservation amongst Ku homologs.
Through this investigation, we identified two important regions of the Ku70 vWA
domain in response to IR (Chapter 2). Firstly, helix 5, particularly residues D192/D195,
is required for efficient completion of NHEJ. Mutation of these residues to alanine results
in severely compromised survival in response to IR. The analysis of DNA repair
efficiency demonstrated that this mutation greatly decreases DNA repair capacity relative
to WT, indicating that the survival defect was due to a loss of NHEJ capability. Next, the
mutation of S155 to alanine produced a surprising phenotype. Unlike what would be
expected of a mutation impairing DNA repair, alanine substitution of this residue resulted
in increased survival in response to IR. There was decreased activation of the ATF2
dependent DDR cascade that resulted in decreased activation of apoptosis. Given the
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prevalence of serine phosphorylation in the DDR, we hypothesized that this alanine
substitution was preventing a phosphorylation event at this residue that is required for the
DDR activation of apoptosis in the event of unsuccessful repair. We went on to confirm
this phosphorylation (Chapter 3) event and utilized a phosphomimetic mutant (S155D) to
demonstrate that this modification after IR is required for the interaction and inhibition of
the kinase Aurora B. Expression of the phosphomimetic mutant induces a profound
phenotype, marked by constitutive activation of DDR and cell cycle arrest in the absence
of damage. These results suggested that phosphorylation of S155 occurred after IR,
perhaps in the case of overwhelming damage, in order to mediate the inhibition of Aurora
B and induce cell cycle arrest or activation of apoptosis.

4.2

Ku70 vWA domain in DNA repair

Our work has identified helix 5 of the Ku70 vWA domain has being essential for
DNA repair in MEFs (1). The requirement for these residues appears to be conserved
amongst eukaryotes as it has also been shown to be required for DNA repair in yeast. A
previous study by Ribes-Zamora et al., using S. cerevisiae as an experimental system,
investigated the requirement for certain residues in DNA repair by performing random
mutagenesis across the entire Ku heterodimer followed by in vitro plasmid repair assay
(2). They identified the mutation of residues R189A/D192A/D195R in helix 5 the Ku70
vWA domain as conferring a DNA repair defect. They later confirmed our results in a
mammalian system, demonstrating that the transfection of a Ku70 D192A/D195R mutant
into human cell lines resulted in significantly decreased survival in response to IR
compared to the WT control (3).
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Despite the evidence that the Ku70 vWA helix 5 is required for efficient NHEJ in
response to IR, we have yet to elucidate the exact role of these residues. As a proteinprotein interaction domain, we hypothesize that this region mediates the recruitment of
NHEJ factors to the break and the mutation is preventing this recruitment and therefore
hindering completion of break repair. There are numerous possibilities given number of
proteins involved in processing and ligation of a DSB, however making some
assumptions based on the data available can reasonably narrow the pool of candidates.
Firstly, this mutation inhibits the repair of relatively simple DSBs generated from
endonucleases in a plasmid repair assay (2, 4) as well as confers a dramatic survival
defect after IR, which produces a variety of complex DSBs (5-7). Thus, it seems unlikely
that it would be recruiting an accessory processing factor but instead a member of the
core NHEJ machinery required to ligate even basic DSBs (8). Secondly, although the
mechanism of NHEJ is a fairly conserved process amongst eukaryotes, there are several
participants in mammalian NHEJ that are not present in yeast. For example, there is no
obvious yeast homolog for DNA-PKCS, so it is unlikely that this helix is required for
recruitment and formation of the DNA-PK complex. Instead the focus should be placed
on proteins that have homologs across eukaryotic organisms, such as ligase IV and
XRCC4, which have direct homologs in yeast (9).
This question would be best addressed using a system to monitor DSBs in an in
vivo setting, such as laser microirradiation (micro-IR). This technique utilizes highpowered lasers from confocal microscopy to generate a dense cluster of DNA damage in
discrete locations in the nucleus (10, 11). This method allows for the visualization of
NHEJ proteins at the site of damage due to their concentration at a specific location,
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unlike conventional DNA damaging agents that produce uniform damage throughout the
nucleus, and therefore a diffuse localization of proteins (10, 11). Through this system,
one can monitor the accumulation of NHEJ factors at the break and determine if the
mutation of D192A/D195R is preventing the recruitment of a factor essential for the
completion of NHEJ.
Interestingly, Ribes-Zamora et al. propose that this helix 5 is required to mediate
heterotetramerization of two Ku dimers (3). They suggest that after Ku molecules load
onto the ends, this region mediates the bridging of the DNA. Their results did indeed
demonstrate that mutation of helix 5 decreased co-immunoprecipitation between
transfected Ku molecules relative to their WT counterparts. However, these experiments
were performed in the absence of DNA and in DNA-PKCS deficient cells and therefore do
not accurately represent the conditions of in vivo NHEJ, and does not definitively prove
that this helix is required for DNA end bridging. Previously, an in vitro DNA end
bridging assay demonstrated that the presence of Ku promoted the association of two
DNA molecules (12). Instead of testing the ability of Ku70 D192A/D195R mutants to
associate with each other, a DNA end-bridging assay may be more informative regarding
whether this mutation impairs the ability of Ku to bring two DNA molecules together.

4.3

Ku70 vWA in DNA damage signaling

The coordination between DNA repair and the cell cycle and apoptotic machinery
is an essential part of the DDR. This is required to relay the signal of completed repair to
terminate cell cycle checkpoints, or perhaps in the case of complicated or unsuccessful
repair, to induce prolonged cell cycle arrest and the activation of apoptosis. We propose
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that the phosphorylation of S155 on Ku70 acts as one of these coordinating signals
between NHEJ and the DDR.
Our initial observations suggested a role for S155 distinct from DNA repair.
S155A expressing MEFs demonstrated increased survival and decreased activation of
apoptosis in response to IR treatment. This mutant also displays decreased activation of
several DDR markers after IR, including ATM and the ATF2-dependent signaling
pathway. Interestingly, we confirmed that this residue does not appear to play a role in
NHEJ, as the mutation had no impact on DNA repair efficiency, and was even able to
rescue survival when introduced in conjunction with our established DNA repair mutant
(D192A/D195R). Therefore, we hypothesize that this residue is required for the
activation of cell cycle checkpoints and apoptosis in response to IR, likely in the event of
unsuccessful repair and persistent DSBs. Indeed, we observed the prolonged presence of
ϒ-H2AX foci in S155A MEFs after IR, a phenotype previously observed in cells
surviving with unrepaired breaks (13), indicative of the cells not properly activating
apoptosis in response to irreparable damage. This notion is further supported by the
phenotype of our phosphomimetic mutant (S155D), which we hypothesize would act as
constitutive signal for unrepaired breaks. This mutation confers extremely low survival in
response to IR, and the constitutive activation of DDR markers and cell cycle checkpoints
in the absence of any ectopic DNA damage. In contrast, the alanine substitution mimics a
constitutively unphosphorylated residue and is able to bypass cell cycle arrest and
apoptosis despite persistent DNA damage.
An important consequence of S155 phosphorylation that we have uncovered is the
modulation of Aurora B activity. We observed an interaction between the Ku70 S155D
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mutant and an inhibition of Aurora B activity in S155D expressing MEFs. Furthermore,
the phenotype of cells treated with an Aurora B chemical inhibitor closely mimics that of
our S155D mutant. We hypothesize that following Ku recruitment to the DSB, Ku70
S155 is phosphorylated, and this promotes interaction with Aurora B to inhibit its kinase
activity. We postulate that this event occurs in response to overwhelming or complicated
damage in order to induce cell cycle arrest. Indeed, we observed an interaction between
endogenous WT Ku70 and Aurora B after the introduction of DNA damage but not in
control (untreated) cells. Aurora B activity was also inhibited following IR treatment in
WT Ku70 cells, but this inhibition was blocked by the S155A mutation, confirming that
the phosphorylation is required for Aurora B inhibition.
In order to fully understand the mechanism of inhibition of pS155 Ku70 on
Aurora B, it is important to elucidate the spatio-temporal control of both Ku70
phosphorylation and the inhibition of Aurora B activity. If Ku70 phosphorylation is used
as a signal of delayed or unsuccessful repair, then this would be an event that occurs at a
small subset of breaks, and would likely not appear until after the first 30 minutes, when
the vast majority of simple breaks are resolved and NHEJ complexes dissociated (8). It
remains to be determined which kinase is responsible for the phosphorylation of S155 as
there is a large array of serine/threonine kinases involved in the DDR. The use of
bioinformatics tools designed to predict phosphorylation based on the known consensus
motifs of various kinases did not pinpoint any in particular with a strong likelihood (14,
15). While there are many possibilities, a strong candidate is ATM. ATM activity is often
dispensable for simple NHEJ repair, but it is required for the completion of lengthy
repair, reactions that would often induce prolonged cell cycle arrest as observed in the
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S155D MEFs (8, 16). Furthermore, ATM is involved in promoting its own positive
feedback loop that amplifies its signal and maintains the prolonged signaling cascade
required to sustain cell cycle arrest (17, 18). Since S155 phosphorylation controls the
activation of ATM after IR, it could be yet another mechanism by which ATM
propagates its own signaling cascade.
Unfortunately, addressing these questions has proved challenging thus far. We
were able to observe S155 phosphorylation after IR by utilizing MALDI-TOF MS/MS,
however this technique is not conducive to the finite monitoring of the phosphorylation
and dephosphorylation of S155 due to the method’s insensitivity and large abundance of
material required. The kinetics of Ku phosphorylation after IR in vivo would be best
analyzed by western blot or immunofluorescence. We attempted to generate a phosphospecific antibody directed against this site, but this antibody cross-reacted with other
proteins and could not be utilized for further studies. The successful generation of a
phospho-S155 antibody would be an invaluable tool for understanding the timing and
necessary kinase activity for Ku phosphorylation.
While we have established that an interaction between Aurora B and pS155-Ku70
mediates the inhibition of Aurora following DNA, we now need to establish the nature of
this interaction. The regulation of Aurora B is achieved through the binding of a variety
of different cofactors. Aurora B, for example, is most well known for its participation in
the chromosomal passenger complex, where it interacts with subunits INCENP, Survivin
and Borealin that stimulate its kinase activity towards several substrates in mitosis (19).
Aurora B only makes direct contact with INCENP, with its N-terminal regulatory and
catalytic domains of Aurora B interacting with the IN box motif of INCENP, a
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requirement for basal kinase activity at the kinetochore (20, 21). The other subunits do
not interact directly but are involved in the correct localization and clustering of Aurora B
molecules that are essential for full activity (22). Therefore, it is possible that Ku is
directly modulating kinase by binding and hindrance of the catalytic domain, binding the
regulatory region to induce unfavorable conformational changes or precluding the
interactions with activator subunits. It is also possible that Ku and Aurora B do not
interact directly and their association is mediated by another factor.
The role of Aurora B following DNA damage is not well understood. Aurora B
kinase activity has been shown by us and others to be inhibited following DNA damage
(23), but whether Aurora B is recruited to DSBs has never been demonstrated. This is not
entirely surprising if its recruitment is dependent upon an interaction with Ku however,
since Ku does not assemble at a break in large enough numbers to be visible by
conventional microscopy. Similar to what is utilized to visualize NHEJ factors at the
break, micro-IR would be an excellent tool for observing the localization of Aurora B to
DSBs and determine the time course of its interaction with Ku. Another unknown is the
link between inhibition of Aurora B and the activation of ATM signaling. Aurora B has
actually been shown to activate ATM by phosphorylating serine 1403, but this event was
shown to specifically mediate the spindle assembly checkpoint in mitosis (24). Our
results point to DNA damage specific role for Aurora B regulation of ATM, not
dependent upon any particular cell cycle phase, and this remains to be clarified. There are
some indirect connections between Aurora B and ATM, with an interesting one involving
the protein Repo-man. During mitosis, Repo-man is required for correct Aurora B
localization but also counteracts Aurora B activity by dephosphorylating several of its
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substrates (25, 26). Repo-man has also been shown to localize with inhibit ATM activity,
only to be released from chromatin after DNA damage to allow ATM activation (27). It is
possible that following DNA damage, Repo-man is released from ATM and complexes
with Ku70 and Aurora B to inhibit its activity, but this remains to be investigated.
It is currently unclear whether the effects of the S155 mutants can all be attributed
to Aurora B activity, or whether there are additional signaling events occurring following
Ku70 S155 phosphorylation. In Chapter 2, we describe the expression of S155A
repressing the activation of an ATF2 dependent DDR, resulting in the deregulation of
several ATF2 transcriptional targets such as ATF3 and CHOP (28). While this could be a
distinct signaling pathway regulated by S155 phosphorylation, there have been studies
demonstrating that many of the effects of Aurora B inhibition are dependent upon the
activation of the p38 kinase pathway, a kinase that is the main regulator of ATF2 (29-31).
The repression of ATF2 signaling after IR in S155A cells could be explained by a loss of
Aurora B inhibition and subsequent lack of p38 pathway activation. If the gene
expression changes observed after S155D expression are due to the Aurora B dependent
activation of the p38 pathway, it would be interesting to test whether the use of a p38
inhibitor could rescue its dramatic phenotype. However, there are other gene expression
changes that cannot be explained by Aurora B inhibition. In an examination of the
microarray data obtained from S155D expressing MEFs relative to WT (Supplementary
Table 3-1), it is interesting to note that a large number of phosphatases are found
downregulated following S155D expression. This is consistent with a constitutively
active DDR and cell cycle arrest, as phosphatases are required to resolve checkpoints and
resume normal cycling after the repair of damage (32, 33). Yet, the downregulation and
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inhibition of phosphatases has been demonstrated to increase Aurora kinase activity,
which is in clear opposition of our findings (34, 35). This apparent contradiction could be
due to additional factors or pathways being modulated by S155 phosphorylation that are
independent of Aurora B activity.

4.4

Conclusion

In summary, this work has contributed to the broader understanding of the Ku70
vWA domain function in response to DSBs on two fronts: demonstrating the requirement
for helix 5 for proper DSB repair in mammalian cells, and identifying a novel
phosphorylation site that signals to the DDR to modulate cell fate decisions. We propose
a model for the function of the Ku70 vWA domain in NHEJ (Figure 4-1) where Ku is
rapidly recruited to a DSB, and helix 5 participates in the completion of NHEJ by either
mediating the recruitment of another essential NHEJ factor, or the interaction with
another Ku heterodimer at the break. If repair cannot be completed, S155 is
phosphorylated, and this results in the inhibition of Aurora B activity, thereby inducing
prolonged cell cycle arrest or the activation of apoptosis.
A thorough understanding of DNA repair and the DDR has broad implications for
human health as genome instability is a hallmark of cancer (36). We now understand that
Ku not only is involved in the repair of breaks, but also through the phosphorylation of
S155, is essential for the elimination of cells damaged beyond repair. The loss of this
regulation would lead to the proliferation of unstable cells, potentially resulting in
genomic instability and cancer. It would be interesting to investigate the consequences of
a S155 alanine substitution at the organismal level, and whether the loss of this
phosphorylation has oncogenic potential. On the contrary, we have observed that the
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Figure 4-1 Model for the function of the Ku70 vWA domain in response to DSBs.
(A) Following recruitment of the Ku heterodimer to the break, the Ku70 α-helix 5 is
positioned inwards towards the DNA end. This helix is required for NHEJ and cell
survival in response to DSBs, and there are currently two hypotheses to explain its role:
(i) protein-protein interaction surface utilized in the recruitment of an essential NHEJ
factor,

(ii)

interaction

surface

between

two

Ku70

molecules

to

mediate

heterotetramerization of Ku in order to bridge DNA ends at the break. (B) (i) Ku attempts
repair by NHEJ (ii) Following unsuccessful or prolonged repair, an unknown kinase
phosphorylates Ku70 on residue serine 155. (iii) Ku70 pS155 interacts with Aurora B
kinase, either directly or indirectly, in order to inhibit Aurora B kinase activity. (iv)
Inhibition of Aurora B kinase results in increased activity of ATM and ATF2 and
upregulation of p21, leading to the activitation of cell cycle checkpoints, senescence and
apoptosis.
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transfection of the S155D vWA had a profound effect on both mouse and human cell
lines, inducing cell cycle arrest and senescence, through a modulation of Aurora B
activity. Given the prevalence of small molecules being generated against the Aurora
kinases for the treatment of cancer, it raises the possibility of whether this
phosphomimetic peptide of Ku has therapeutic potential.
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